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Summary 
 
Cohesin is a multiprotein complex composed of four subunits: SMC1, SMC3, Rad21 and 
SA. Within its ring-shape, two DNA fibers can be held together. Cohesin is best known 
for its role in cohesion by stably entrapping sister chromatids. In addition, cohesin can 
also form loops by bringing together distal regions from the same chromatid. This 
property establishes cohesin as a major organizer of interphase chromatin, which is 
essential for gene regulation among other processes. In somatic vertebrate cells, the SA 
subunit can be either SA1 or SA2, thus giving rise to two coexisting cohesin variants: 
cohesin-SA1 and cohesin-SA2. Despite their similarity, both proteins are functionally 
non-redundant, best exemplified by the lethality of SA1-null embryos. STAG2, the gene 
encoding SA2, is one of the most frequently mutated genes across multiple cancer types, 
and recently germline mutations have also been identified in developmental syndromes 
known as cohesinopathies. 
In this Thesis, we generated a Stag2 conditional knock out (cKO) mouse model to shed 
light onto the functional specificities of cohesin variants and address the consequences 
of SA2 loss both in vitro, in murine embryonic fibroblasts (MEFs), and in vivo, for 
embryonic development. We found that SA2 is dispensable in vitro, but its depletion 
leads to slower proliferation and reduced fidelity of chromosome segregation. We also 
show that the genome wide distribution of cohesin-SA2 in MEFs is not identical to that 
of cohesin-SA1. While both complexes can be found at sites also bound by the insulator 
protein CTCF, a fraction of cohesin-SA2 is present at enhancers independently of CTCF. 
These sites cannot be occupied by cohesin-SA1 even when SA2 is absent, which likely 
alters gene expression. We demonstrate that the association of cohesin-SA2 with 
chromatin is more dynamic than that of cohesin-SA1, a feature that likely explain the 
distinct distribution of the two variants  and the different transcriptional signatures in 
MEFs lacking SA1 or SA2. 
Despite being dispensable for cell viability in vitro, cohesin-SA2 is critical for embryonic 
development. SA2-null embryos die by mid-gestation, displaying a systemic 
developmental delay along with specific heart defects that result from a general reduction 
in proliferation and impaired morphogenesis resulting from altered transcription. We 
uncovered that a particular pool of cardiac progenitors requires SA2 to efficiently deploy 
into the elongating heart tube and contribute to its differentiation. These results support 
a unique role for cohesin-SA2 during embryogenesis that cannot be assumed by 
cohesin-SA1, and suggest a causal relationship between STAG2 mutations and cardiac 
anomalies in cohesinopathy patients. 
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Resumen 
 
La cohesina es un complejo multiproteico en forma de anillo compuesto por SMC1, 
SMC3, Rad21 y SA, que abraza la fibra de ADN. Además de su papel en el 
apareamiento de cromátidas hermanas o cohesión, puede formar lazos de cromatina al 
abrazar regiones distales de una misma cromátida. Esta propiedad establece a la 
cohesina como un importante organizador de la cromatina interfásica, esencial para la 
regulación génica entre otros procesos. En células somáticas de organismos 
vertebrados, la subunidad SA puede ser SA1 o SA2, dando lugar a dos variantes que 
coexisten en todas las células: cohesina-SA1 y cohesina-SA2. A pesar de su similitud, 
los dos complejos no son redundantes, siendo la mejor prueba de ello la letalidad de los 
embriones murinos carentes de SA1. STAG2, el gen que codifica SA2, es uno de los 
más mutados en cáncer, y recientemente se han identificado mutaciones en la línea 
germinal en pacientes de síndromes de desarrollo conocidos como cohesinopatías. 
En esta Tesis hemos generado un modelo de ratón knock out condicional de Stag2 para 
esclarecer la especificidad funcional de las variantes de cohesina y estudiar las 
consecuencias de eliminar SA2 tanto in vitro, en fibroblastos embrionarios de ratón, 
como in vivo, durante el desarrollo embrionario. Observamos que SA2 es dispensable 
in vitro, pero su depleción conlleva una proliferación más lenta y una menor fidelidad en 
segregación cromosómica. También mostramos que la distribución genómica de las dos 
variantes no es idéntica. Mientras ambas ocupan sitios donde también se une CTCF, 
una fracción de los complejos cohesina-SA2 se encuentra en enhancers independien-
temente de CTCF. Estos sitios no pueden ser ocupados por cohesina-SA1, incluso en 
ausencia de cohesina-SA2, lo que altera la expresión génica. Demostramos que la 
asociación de cohesina-SA2 a cromatina es más dinámica que la de cohesina-SA1, lo 
que probablemente determina su distribución genómica y contribuye a explicar que los 
cambios transcripcionales en células carentes de SA1 o SA2 sean muy diferentes. 
A pesar de ser dispensable para la viabilidad celular in vitro, la cohesina-SA2 es crítica 
para el desarrollo embrionario. En su ausencia, los embriones mueren a mitad del 
período de gestación y presentan un retraso de crecimiento sistémico y defectos 
específicos en el corazón. Estos defectos se deben a una menor proliferación y a 
alteraciones transcripcionales que afectan a la migración de una población de 
progenitores cardiacos hacia el tubo cardiaco durante su elongación. Así pues, hemos 
identificado un papel único de la cohesina-SA2 en la morfogénesis del corazón en el 
desarrollo embrionario que sugiere una relación causal entre mutaciones en STAG2 y 
las anomalías cardiacas de los pacientes de cohesinopatías. 
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Abbreviations 
 
AML  Acute myeloid leukemia 
3C  Chromosome Conformation Capture 
ASHF  Anterior secondary heart field 
AVC  Atrioventricular canal 
BrdU  Bromodeoxyuridine 
CdLS  Cornelia de Lange Syndrome 
ChIP-seq  Chromatin Immunoprecipitation coupled with deep sequencing 
cKO  Conditional knock out 
CNV  Copy number variation 
co-IP  Co-Immunoprecipitation 
CTCF  CCCTC-binding factor 
DEG   Differentially Expressed Gene 
Esco1/2 Establishment of Cohesion 1/2 
FACS  Fluorescence Activated Cell Sorting 
FC  Fold Change 
FDR  False Discovery Rate 
FHF  First heart field 
FPKM  Fragments per kilobase per million of reads 
FRAP  Fluorescence Recovery After Photobleaching 
GO  Gene Ontology 
GSEA  Gene Set Enrichment Analysis 
H3P  Histone H3 phosphorylated at Serine 10 
HC  Heart chambers 
HDAC8 Histone Deacetylase 8 
HEAT  Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A) 
and the yeast kinase TOR1 
HR  Homologous Recombination 
HSPC  Hematopoietic stem and progenitor cell 
IB  Immunoblot 
iFRAP  inverse Fluorescence Recovery After Photobleaching 
IFT  Inflow tract 
ISL1  Islet1 transcription factor 
KO  knock out 
LA  Left atrium 
LV  Left ventricle 
MEFs  Mouse Embryonic Fibroblasts 
mESC  Mouse Embryonic Stem Cell 
NES  Normalized Enrichment Score 
NIPBL  Nipped-B-like protein 
ns  non-significant 
NT  Neural tube 
OFT  Outflow tract 
Pds5  Precocious dissociation of sisters 5 
PP2A  Protein Phosphatase 2A 
PSHF  Posterior secondary heart field 
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RA  Right atrium 
RAD21 Double-strand-break repair protein 21 homolog 
RBS  Roberts Syndrome 
RNA-seq RNA-sequencing 
RNApolII RNA polymerase II 
RT-qPCR Retrotranscription followed by quantitative PCR 
RV  Right ventricle 
SA  Stromal Antigen (protein) 
scRNA-seq Single cell RNA-seq 
SEC  Super-elongation complex 
SEM  Standard error of the mean 
Sgo1  Shugoshin 1 
sgRNA short guide RNA 
SHF  Secondary heart field 
siRNA  small interfering RNA 
SMC  Structural Maintenance of Chromosomes 
STAG  Stromal Antigen (gene) 
TAD  Topologically Associating Domain 
tSNE  t-Distributed Stochastic Neighbor Embedding 
TSS  Transcription Start Site 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling 
WAPL  Wings apart-like protein 
WT  wild type 
XCi  X chromosome inactivation 
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Introduction 
 
1. The cohesin complex 
 
Cohesin is a large multiprotein complex conserved from yeast to human, which 
orchestrates multiple DNA transactions within the nucleus. Cohesin is one of the 
complexes of the Structural Maintenance of Chromosomes (SMC) family that exist in 
eukaryotic cells, together with condensin and the SMC5/6 complex, but SMC complexes 
exist in all kingdoms of life (Uhlmann 2016). Cohesin subunits were originally identified 
in yeast screenings as mutants of sister chromatid cohesion (Guacci et al. 1997; 
Michaelis et al. 1997) and were soon after shown to form a complex in Xenopus laevis 
egg extracts and human cells (Losada et al. 1998, 2000; Sumara et al. 2000). Since 
then, cohesin has been attributed a well-established role in mediating sister chromatid 
cohesion, which is essential for chromosome segregation in mitosis and meiosis and 
DNA repair by homologous recombination (HR). Emerging research over the last decade 
has also recognized cohesin as major player in higher-order genome organization 
through chromatin looping, thereby regulating gene expression and replication timing 
(Nasmyth & Haering 2009). Additional roles of cohesin include fork progression, 
architecture of DNA replication factories, VDJ recombination and locus rearrangement, 
most of which are the consequence of genome organization. 
 
1.1 Cohesin composition 
 
Cohesin is a ring-shaped complex composed of two SMC proteins, a kleisin subunit and 
a Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A) and yeast kinase 
TOR1 (HEAT)-repeat protein (Fig. I1A). SMCs are long rod-like proteins that fold on 
themselves to create a hinge domain on one end and an ATPase head domain 
containing the N- and C-terminus on the other, separated by long anti-parallel coiled 
coils. When SMCs heterodimerize they form a symmetrical structure that interacts 
through the hinge domains. The non-SMC subunits form a globular domain in between 
the catalytic domains (Anderson et al. 2002) (Fig. I1B). 
 
The SMC proteins that compose cohesin are SMC1 and SMC3. A tripartite ring is formed 
by interaction with the kleisin Rad21, that bridges the head domains through interaction 
of its C- and N-terminal domains near the SMC1 and SMC3 heads, respectively. The 
HEAT-repeat protein Stromal Antigen (SA) is the fourth subunit that completes the core 
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cohesin complex through binding to Rad21 (Gligoris et al. 2014; Hara et al. 2014). This 
region serves as an interaction platform for cohesin regulatory proteins. 
 
 
Figure I1. The cohesin complex. 
A. Composition of the somatic cohesin complex. SMC3 and SMC1A form a heterodimer 
tethered by the hinge domains. SMC head domains are bridged by the kleisin subunit 
Rad21 to form a tripartite ring that is completed by binding of the HEAT-repeat protein 
Stromal Antigen (SA). In somatic vertebrate cells, the SA subunit can be either SA1 
or SA2. Meiosis-specific versions exist for all cohesin subunits except SMC3 (not 
depicted). 
B. Electron micrographs of human cohesin complexes purified from HeLa cells. Taken 
from Anderson et al. 2002. 
 
Intriguingly, two versions of cohesin coexist in somatic vertebrate cells, that contain one 
of two variants of the SA subunit: SA1 or SA2. This Thesis focuses only on somatic 
cohesin complexes, although meiosis-specific versions exist for all cohesin subunits 
except SMC3 (Biswas et al. 2016; Llano et al. 2012). This leads to a wide array of 
different cohesin complexes depending on the combination of subunits. 
 
1.2 DNA entrapment by cohesin 
 
Evidence from a number of in vitro and in vivo studies supports a model in which cohesin 
can topologically entrap a chromatin fiber within the lumen of its ring-shaped structure 
(Gruber et al. 2003; Haering et al. 2008). DNA entrapment is essential for cohesin 
functions. Both for its role in cohesion between sister chromatids (trans entrapment, Fig. 
I2A) and for its role in chromatin looping (cis entrapment, Fig. I2B), cohesin would need 
to tether two different DNA strands at the same time. 
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Figure I2. Two modes of cohesin-mediated entrapment of chromatin fibers. 
Cohesin can embrace (A) two sister chromatids in trans to perform cohesion or also B) entrap 
two distal DNA fragments of the same chromatid in cis to form loops involved in chromatin 
organization. 
 
Different models have been proposed to account for this (Fig. I3). The classical 
“embrace” model suggests that both chromatin fibers are entrapped within the lumen of 
one cohesin ring (Gruber et al. 2003; Haering et al. 2008). A second model, known as 
the “handcuff” model, proposes that two cohesin rings associated through their SA 
subunit each entrap one chromatin fiber (Zhang et al. 2008a). Alternatively, one cohesin 
complex could entrap two fibers within two potential compartments in the same ring in a 
“two gates” model that could reconcile the two previous ones. This idea is driven by the 
rapidly growing amount of data about the cohesin ring architecture (Nishiyama 2019). 
Whether the two tethered DNA strands are embraced by a single cohesin complex or 
two interacting complexes is still a matter of controversy and could depend on the 
functional nature of the tethering. Very recent data has shown that, at least in vitro, a 
single cohesin is responsible for cis loop formation (Davidson et al. 2019). 
 
Figure I3. Current models of cohesin-mediated entrapment of chromatin fibers. 
The classical “embrace” model suggests that two fibers are held together within the single 
lumen of the cohesin ring. The “handcuff” model proposes that each fiber is held by different 
cohesin complexes that interact. The “two gates” model suggests that SMC head tethering 
creates two distinct compartments within one cohesin ring, each entrapping a fiber. 
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2. Dynamic association of cohesin with chromatin throughout 
the cell cycle 
 
Cohesin’s association with DNA during the different phases of the cell cycle is highly 
dynamic and tightly regulated by different processes: cohesin loading and unloading, 
cohesion establishment and cohesion dissolution. Fluorescence Recovery After 
Photobleaching (FRAP) studies have shed light on the distinct cohesin populations in 
the cell. While a fraction of cohesin remains soluble in the nucleus, another is 
dynamically associated to chromatin throughout the cell cycle. In addition, a third and 
very stable cohesin population arises from S phase onwards to mediate sister chromatid 
cohesion (Gerlich et al. 2006). 
 
2.1 Loading and unloading of cohesin during interphase 
 
In vertebrate cells, cohesin is loaded onto chromatin as cells exit mitosis, in late 
telophase and early G1. The loading reaction is mediated by the heterodimer formed by 
Nipped B-like protein (NIPBL) and Mau2, that binds to cohesin and stimulates ATP 
hydrolysis by the SMC heads (Arumugam et al. 2006; Gillespie & Hirano 2004). This 
allows entrapment of DNA through opening of the “entry gate”, consisting of separation 
of the SMC hinge domains (Gruber et al. 2006) (Fig. I4). 
 
Once loaded, cohesin binding to chromatin is dynamic. Two other HEAT-repeat proteins 
associate with cohesin to modulate its association to chromatin: Precocious dissociation 
of sisters (Pds5), which in somatic vertebrate cells can be Pds5A or Pds5B, and Wings-
apart like protein (WAPL) (Gandhi et al. 2006; Kueng et al. 2006; Losada et al. 2005; 
Sumara et al. 2000). Both proteins work together to promote cohesin unloading through 
the ATP-dependent opening of an “exit gate” consisting in separation of the SMC3-
Rad21 interface (Gligoris et al. 2014; Huis In’t Veld et al. 2014; Murayama & Uhlmann 
2015; Ouyang et al. 2016) (Fig. I4). 
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Figure I4. Mechanism for dynamic loading and unloading of cohesin.  
Cohesin is loaded onto chromatin in interphase by the cohesin loader complex formed by the 
NIPBL-Mau2 heterodimer in an ATP-dependent manner. This allows entrapment of a 
chromatin fiber by stimulating the opening of the “entry gate” between the SMC hinges. Once 
loaded, cohesin is susceptible to removal mediated by Pds5 and WAPL. Binding of both 
factors promotes opening of the “exit gate”, the interface between Rad21 and SMC3. 
 
 
2.2 Cohesion establishment after DNA replication 
 
From the moment they emerge from the replication fork, replicated chromatids need to 
be held together until their separation during mitosis. This process is known as cohesion 
and promotes faithful DNA repair by homologous recombination (HR) in interphase and 
ensures accurate chromosome segregation. During DNA replication a fraction of the 
cellular cohesin pool becomes stably bound to chromatin (Gerlich et al. 2006) and is 
responsible for this tethering, in a tightly regulated manner. 
 
Cohesion establishment requires two events: SMC3 acetylation and Sororin binding (Fig. 
I5). Both events must occur in the context of DNA replication (Ladurner et al. 2016; Lafont 
et al. 2010). In vertebrates, SMC3 acetylation is carried out at residues K105 and K106 
of the head domain by two cohesin acetyltransferases, Esco1 and Esco2. The acetylated 
cohesin complex can then be bound by Sororin, which displaces WAPL and counteracts 
its unloading activity (Ladurner et al. 2016; Nishiyama et al. 2010). Both events are 
facilitated by Pds5. Acetylated cohesin complexes bound by Sororin are the ones 
responsible for cohesion between sister chromatids and persist until mitosis. 
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Figure I5. Cohesion establishment requires SMC3 acetylation and Sororin binding. 
Once DNA is replicated, the cohesin acetyltransferases Esco1/Esco2 acetylate two residues 
in the head domain of SMC3. Next, Sororin is recruited through Pds5, which causes WAPL 
displacement. Acetylated and Sororin-bound cohesin is now stably bound to chromatin, 
promoting cohesion between newly replicated sister chromatids. 
 
 
2.3 Cohesion dissolution in mitosis 
 
Upon mitotic entry, cohesin undergoes a stepwise dissociation from chromatin, first in 
prophase and later in anaphase (Waizenegger et al. 2000) (Fig. I6).  Most cohesin is 
removed in a first step regulated by phosphorylation, known as the prophase pathway. 
Phosphorylation of SA by Polo-like kinase 1 (Plk1) and release of Sororin upon 
phosphorylation by cyclin-dependent kinase 1 (CDK1) and AuroraB restore WAPL 
activity (Gandhi et al. 2006; Hauf et al. 2005; Losada et al. 2002; Nishiyama et al. 2013; 
Shintomi & Hirano 2009). Cohesin can then be released by opening of the cohesin “exit 
gate”. However, a small remaining fraction of cohesin enriched around centromeres 
resists the prophase dissociation pathway to keep sister chromatids together until 
anaphase, through different mechanisms. Shugoshin 1 (Sgo1) and protein phosphatase 
2A (PP2A) antagonize the phosphorylation of SA and Sororin (Liu et al. 2013), while 
Sgo1 by itself competes with WAPL for binding to cohesin (Hara et al. 2014). The 
inhibitory chaperone Securin also avoids cleavage of Rad21 by Separase (Hauf et al. 
2001; Lin et al. 2016; Uhlmann et al. 1999). 
 
The cell enters anaphase when all chromosomes are correctly bioriented, that is, with 
sister kinetochores attached to microtubules from opposite spindle poles. This requires 
dissociation of all remaining cohesin, this time by a cleavage mechanism. Among other 
events, Securin is targeted for proteosomal degradation by the Anaphase Promoting 
Complex/Cyclosome (APC/C), which triggers Rad21 cleavage by Separase and allows 
sister chromatid separation (Musacchio & Salmon 2007). In late telophase and early G1, 
cohesin can again populate chromatin after deacetylation of SMC3 by HDAC8 (Deardorff 
et al. 2012) and the cell cycle can start again. 
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Figure I6. Different mechanisms promote stepwise removal of cohesin during mitosis. 
Most cohesin is unloaded in prophase through Pds5-WAPL-dependent dissociation, as in 
Fig. I3, mediated by phosphorylation signals. Cohesin at the centromeres is protected by the 
activity of Shugoshin 1 (Sgo1) and protein phosphatase (PP2A) to keep chromatids together 
until they are correctly bioriented. Cleavage-mediated removal of cohesin by Separase 
allows anaphase entry. See text for more details. 
 
 
 
3. Cohesin in genome organization 
 
In eukaryotes, the genome does not exist as a linear molecule. Imaging-based methods 
combined with chromosome conformation capture (3C) technologies with increasing 
resolution have shed light on the complex genomic organization. DNA is hierarchically 
packaged inside the nucleus, forming multiscale structural units of increasing complexity: 
chromatin fibers, chromatin loops, topologically associating domains (TADs), 
compartments and chromosome territories (Bonev & Cavalli 2016) (Fig. I7). Packaging 
provides on one side compaction, but also functional compartmentalization on all levels 
that modulates nuclear processes such as cell division, DNA replication and gene 
expression. Overall, eukaryotic genome architecture is crucial for cell fate and animal 
development (Zheng & Xie 2019). 
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Figure I7. Hierarchical chromatin organization at different scales in eukaryotic 
genomes. 
Chromosomes are segmented into active and inactive compartments. Within, topologically 
associating domains (TADs) form functional blocks. Inside, smaller intra-TAD chromatin 
loops are established. Taken from https://genominfo.org/. 
 
Multiple components regulate genomic architecture, such as transcription factors, non-
coding RNAs (ncRNAs) and architectural proteins. Among them, cohesin and CCCTC-
binding factor (CTCF) play a very prominent role in mediating dynamic and functional 
interactions in three dimensions. 
 
Initial studies using chromatin immunoprecipitation followed by deep sequencing (ChIP-
seq), to assess the genome-wide distribution of cohesin, revealed an extensive 
colocalization of cohesin with the architectural protein CTCF (Parelho et al. 2008; Rubio 
et al. 2008; Wendt et al. 2008a). This zinc-finger protein binds DNA directly and early 
work recognized its role in enhancer/promoter insulation (Bell & Felsenfeld 2000; Hark 
et al. 2000). Later, chromosome conformation studies showed the importance of cohesin 
and CTCF in forming chromatin contacts and overall chromosome organization (Sofueva 
et al. 2013; Zuin et al. 2014). 
 
TADs are often demarcated by cohesin and CTCF and are thought to regulate 
transcription by facilitating interactions between enhancers and promoters present in the 
same TAD, while restricting interactions with regulatory elements from different TADs. 
Genes within the same TAD tend to have similar gene expression dynamics, suggesting 
their role in coordinating the activity of a group of genes (Gibcus & Dekker 2013). 
An attractive model for TAD generation proposes that, once loaded, cohesin can extrude 
DNA to generate progressively longer chromatid loops until it dissociates by WAPL-
mediated release or until it gets stalled by an obstacle, such as CTCF binding (de Wit et 
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al. 2015; Fudenberg et al. 2016; Haarhuis et al. 2017; Sanborn et al. 2015) (Fig. I8). A 
very recent study indeed confirmed that cohesin can act as a loop extruder machine in 
vitro and forms progressive chromatin loops in a manner that depends on its ATPase 
activity, stimulated by the cohesin loader (Davidson et al. 2019). 
 
 
Figure I8. Model for cohesin as a loop extrusion factor. 
A. The loop extrusion model for genome folding can explain how certain regions of 
chromosomes stay close together and why cohesin often colocalizes with CTCF at 
its binding sites, forming the anchor of a chromatin loop. According to this model, a 
loop is fed in a progressive manner through the cohesin ring, until cohesin 
encounters CTCF or until it is released from chromatin by WAPL activity.  
B. In vitro evidence for a direct role of cohesin in loop extrusion. Biochemically 
reconstituted human cohesin complexes form loops in DNA tethered at both ends to 
a flow chamber, in the presence of the cohesin loader and ATP. Taken from 
Davidson et al. 2019. 
 
The loop extrusion model could explain why cohesin and CTCF colocalize and why 
increasing cohesin residence time on chromatin causes formation of longer loops 
(Haarhuis et al. 2017; Wutz et al. 2017). It is also consistent with the fact that there is 
very little colocalization of cohesin with its loader (Busslinger et al. 2017; Wendt et al. 
2008b), likely due to sliding of cohesin away from the loading site. This adds a new 
dynamic component to the complex, beyond loading and unloading. Why cohesin stops 
at CTCF sites remains unclear, since CTCF binds to chromatin much more dynamically 
than cohesin (Hansen et al. 2017). Some evidences support a role for Pds5 in this arrest 
(Wutz et al. 2017), maybe mediated by cohesin acetylation, which in G1 is mediated by 
Esco1 exclusively and requires Pds5 (Minamino et al. 2015). 
 
CTCF-cohesin sites can also be found within TADs and contribute to cell-type specific 
sub-TAD organization (Phillips-Cremins et al. 2013). In addition, CTCF-independent 
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cohesin sites have also been identified, in which the complex occupies regions bound 
by tissue-specific transcription factors or transcriptional regulators such as Mediator 
(Faure et al. 2012; Kagey et al. 2010; Schmidt et al. 2010). These findings affirm the role 
of cohesin in establishing contacts at multiple scales. 
 
 
 
4. Two non-redundant versions of cohesin in somatic cells 
 
Somatic vertebrate cells express two paralogs of the cohesin SA subunit, SA1 and SA2 
(Losada et al. 2000; Sumara et al. 2000). Their presence in the ring is mutually exclusive, 
giving rise to two distinct cohesin variants: cohesin-SA1 and cohesin-SA2 (Fig. I9A). 
 
4.1 Sequence and structure of SA1 and SA2 
 
SA1 and SA2 are proteins of 1258 and 1231 aminoacids, respectively. Both SA proteins 
contain 17 HEAT repeats (Hara et al. 2014). They have a high overall degree of 
sequence homology along the central region but differ in their N- and C-terminal regions 
(Fig. I9B). At its N-terminus, SA1 contains an AT-hook that has been proposed to 
mediate association to telomeric DNA (Bisht et al. 2013). This motif is absent in SA2.  
 
Interestingly, crystallization attempts of the full-length SA subunits have failed, as the 
two studies that have solved the crystal structure lack the protein termini. In one, the 
yeast ortholog Scc3 was purified from two species of yeast but was only able to 
crystallize with trimmed N- and C-terminal extensions of the protein (Roig et al. 2014). In 
the other, human SA2 was crystallized as part of a cohesin RAD21-SA2 subcomplex 
containing SA2 residues 80-1260 (Hara et al. 2014) (Fig. I9C). Both studies agree that 
the terminal regions are unstructured and therefore impede crystallization. However, 
these regions are the most variable between SA homologs and may hold the key to their 
specificities. 
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Figure I9. Two different cohesin complexes coexist in somatic vertebrate cells. 
A. Cohesin complexes carrying either SA1 or SA2 are depicted. 
B. Sequence conservation represents the percentage of amino acids (aa) that are 
identical between given regions. Conservation is highest in the central region (79% 
between aa 91-1080), whereas the N and C terminal ends are much more variable 
(33% conservation from aa 1-90 and 45% from aa 1080-end, respectively). 
C. Dragon-shaped crystal structure for SA2 (dark red) containing residues 80-1260 
together with the Rad21 interface (light red). Adapted from Hara et al. 2014. 
 
 
4.2 Unique roles of cohesin-SA1 and cohesin-SA2 
 
Despite their sequence similarity and their comparable chromatin-association dynamics 
throughout the cell cycle, cohesin-SA1 and cohesin-SA2 have non-redundant functions. 
Analysis of mouse and human cells depleted of SA1 or SA2 revealed a preferential 
contribution towards telomeric and centromeric cohesion, respectively (Canudas & Smith 
2009; Remeseiro et al. 2012a) (Fig. I10). In mouse embryonic fibroblasts (MEFs) lacking 
SA1, telomeric cohesion defects lead to defects in telomere replication and, in turn, 
segregation defects (Remeseiro et al. 2012a). Other studies have defined preferential 
roles of cohesin-SA2 in other processes, such as recruitment to UV-induced double-
strand breaks (DSBs) (Kong et al. 2013), repression of transcription near DSBs to allow 
correct repair (Meisenberg et al. 2019) and replication fork progression (Mondal et al. 
2019). 
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Figure I10. Specific roles of cohesin variants in cohesion. 
A. Schematic representation of a specific contribution of SA1 to telomere cohesion and 
SA2 to centromere cohesion. Both contribute to cohesion along chromosome arms. 
B. Representative images of metaphase chromosomes from MEFs wild type, SA1-null 
(SA1-/-) and depleted of SA2 (siSA2). Top, stained with DAPI (grey), showcasing 
centromere cohesion defect in the absence of SA2. Bottom, stained with DAPI (blue) 
and a telomeric repeat FISH probe (red), showing irregular or “fragile” telomeres that 
reflect defective telomere replication in the absence of SA1. Taken from Cuadrado 
et al. 2012. 
 
On the other hand, the vast majority of studies related to the role of cohesin in chromatin 
organization have done so from the perspective of one of the core cohesin components 
(SMC1, SMC3 or Rad21). Global cohesin depletion or removal of cohesin from 
chromatin by NIPBL depletion leads to an overall loss of TADs and loops (Rao et al. 
2017; Schwarzer et al. 2017). 
 
In these studies, however, differences between SA1 and SA2 have not been addressed. 
During the course of this Thesis, our group has published two studies within this scope 
that have uncovered unique functions of cohesin-SA1 and cohesin-SA2 in genome 
organization. In human cell lines, both cohesin variants were both found at sites also 
bound by CTCF, but cohesin-SA1 played a stronger role in stabilizing and demarcating 
TAD boundaries. In addition, cohesin-SA2 also occupied sites without CTCF, involved 
in more local contacts that regulate tissue-specific transcription. At these sites, cohesin-
SA2 could not be replaced by cohesin-SA1 (Kojic et al. 2018). In mouse embryonic stem 
cells (mESCs), a specific contribution of cohesin-SA2 was described to silencing of 
lineage-commitment genes through Polycomb recruitment and activation of pluripotency 
genes through local contacts involving superenhancers (Cuadrado et al. 2019). 
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Despite these differences, either cohesin is sufficient to allow cell proliferation and 
maintain viability in cultured cells (Mondal et al. 2019; Remeseiro et al. 2012a; van der 
Lelij et al. 2017). During embryonic development, however, cohesin-SA1 is essential, 
suggesting that there are functions that cohesin-SA2 is unable to fulfill. SA1-deficient 
mouse embryos from a constitutive knock out mouse model previously generated in our 
group are embryonic lethal starting at E11.5, although some embryos exceptionally 
survive until later stages of development (E17.5, Fig. I11). When analyzed, they 
displayed severe developmental abnormalities and hypoplasia at the organismal level, 
as well as gene deregulation at the cellular level (Remeseiro et al. 2012b).  
 
 
Figure I11. SA1-null mice are embryonic lethal.  
Lethality of constitutive SA1KO embryos onsets at E11.5 but some survive until later stages. 
Wild type (WT) and SA1 knock out (SA1KO) embryos at E17.5 are shown. Data from 
Remeseiro et al. 2012b. 
 
Overall, while cohesin-SA1 and cohesin-SA2 may have roles in which both complexes 
are interchangeable, it has become increasingly clear that they have non-redundant 
functions. Further elucidating these functions is one of the main goals of this Thesis and 
can hold relevant implications for development and disease, as highlighted in the next 
section. 
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5. Cohesin in development and disease 
 
5.1 Cohesin and development 
 
The development of a complex multicellular organism requires two fundamental 
processes: one is cell proliferation, needed for growth; the other is cell differentiation, in 
order to generate specialized cells and structures. Cohesin plays key roles in both these 
processes and is therefore essential for coordinating development (Remeseiro et al. 
2013b). Several mutant mouse models for cohesin have been reported. Homozygous 
mutations in common cohesin subunits Rad21 or SMC3 are early embryonic lethal, but 
heterozygous mutants can be tolerated. Rad21 heterozygous mice display increased 
radiosensitivity and defective DSB repair (Xu et al. 2010), while SMC3 heterozygous 
mice show reduced body weight, craniofacial defects and impaired hematopoiesis 
(Wang et al. 2019; White et al. 2013). Mouse models with tissue-specific deletion of 
cohesin have also been reported. Depletion of SMC3 in the hematopoietic compartment 
leads to aberrant hematopoiesis with an altered balance between self-renewal and 
differentiation (Viny et al. 2015), while depletion in the brain leads to an abnormal 
neurological and behavioral phenotype (Fujita et al. 2017). 
 
Given the wide scope of cohesin functions, its dysfunction is likely to alter many biological 
processes simultaneously, but not all of them have proven to be equally sensitive. While 
sufficient cohesion can be achieved with low cohesin levels (Carvalhal et al. 2018; 
Heidinger-Pauli et al. 2010), developmental defects and transcriptional alterations can 
arise with only small reductions (e.g. NIPBL heterozygous mice; Kawauchi et al. 2009; 
Muto et al. 2011). It is conceivable that cohesin’s role in gene expression, for instance, 
may be much more sensitive to cohesin dosage than cohesion-related functions.  
 
Three-dimensional genome architecture modulates biological processes including DNA 
replication, cell division and transcription, and as such is crucial for cell differentiation 
and multicellular organism development (Zheng & Xie 2019). As explained before, 
cohesin and CTCF have a crucial role in genome organization and mediate long-distance 
and local contacts that orchestrate gene regulation. They contribute to the genomic 
landscape that is established very early during embryonic development and are involved 
in later contact rewiring in the transition from a totipotent to a lineage-committed state 
(Hug & Vaquerizas 2018), ultimately affecting development and cell fate. It is not 
surprising that defects in regulatory contacts mediated by cohesin and CTCF can have 
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pathogenic consequences and lead to developmental abnormalities (Lupiáñez et al. 
2016). Studies have shown that TAD disruption can cause “enhancer adoption” or 
establishment of ectopic enhancer-promoter contacts across regions that would normally 
be insulated, causing misexpression and disease (Ibn-Salem et al. 2014; Lupiáñez et al. 
2015). TAD reorganization is also expected to play a role in the pathogenesis of cancer, 
for example in acute myeloid leukemia (AML) (Gröschel et al. 2014). Aberrant expression 
of single genes by altered local intra-TAD contact can also have potentially pathogenic 
consequences. 
 
Cohesin pathway mutations lie at the origin of developmental syndromes, discussed 
below, highlighting its importance for correct organismal differentiation and development.  
 
 
5.2 Developmental syndromes associated with cohesin mutations 
 
Mutations in the cohesin pathway cause multispectrum developmental disorders 
collectively known as “cohesinopathies”. The most characterized ones are Cornelia de 
Lange syndrome (CdLS) and Roberts syndrome (RBS). They entail clinical phenotypes 
that include intellectual deficiency, growth retardation, craniofacial dysmorphism, limb 
defects and cardiac malformations (Piché et al. 2019). CdLS affects 1 individual in every 
10,000 live births. Most cases of CdLS are caused by inactivating mutations in the gene 
encoding NIPBL, causing haploinsufficiency, but mutations in SMC1A, SMC3, RAD21 
and HDAC8 are also found to a lesser extent. Cells from CdLS patients or mouse models 
of CdLS do not exhibit obvious cohesion defects but have altered transcription 
(Kawauchi et al. 2009; Remeseiro et al. 2013a). RBS is rarer and caused by homozygous 
mutations in the gene encoding Esco2, a cohesin acetyltransferase. Unlike for CdLS, 
RBS patients exhibit premature centromere separation, aneuploidy and other defects 
related to cohesion loss (Whelan et al. 2012). Despite arising from mutations in a 
common cohesin pathway and having overlapping phenotypes, the underlying 
mechanisms for both syndromes are currently believed to be distinct. 
 
More recently, a new genetic disorder with strong resemblance to CdLS was discovered: 
CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O 
for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia). 
This syndrome is caused by gain-of-function mutations in the gene encoding AFF4, a 
member of the super elongation complex (SEC) that mobilizes paused RNA polymerase 
II. The mutations cause aberrant genomic distribution of both AFF4 and cohesin around 
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active genes, which was also observed in CdLS, in both cases leading to similar 
transcriptional deregulation (Izumi et al. 2015). The similarities could point to a common 
mechanism of pathogenesis in both syndromes related with the role of cohesin in gene 
regulation. 
 
In recent years, clinical exome sequencing (CES) has revealed de novo germline 
mutations in STAG1 and STAG2, genes encoding SA1 and SA2, respectively. The 
clinical features of the patients partially overlap with those of CdLS and other 
cohesinopathies, thus further expanding the genetic heterogeneity underlying these 
syndromes. For STAG1, 20 cases have been described with heterozygous mutations or 
microdeletions of the gene (Lehalle et al. 2017; Yuan et al. 2019). For STAG2, a total of 
22 patients with mutations have been identified. The majority of them are female, but the 
fact that it is an X-linked gene has to be considered. Mutations in females are carried in 
heterozygosis and can be either missense or truncating (Aoi et al. 2019; Kruszka et al. 
2019; Mullegama et al. 2017; Yuan et al. 2019). However, male patients with STAG2 
mutations have also been identified. These are carried in hemizygosis and are 
exclusively missense (Soardi et al. 2017; Yuan et al. 2019). A single case of a truncating 
mutation was found in a foetus that was lost at mid-pregnancy (Aoi et al. 2019). These 
findings are consistent with the prediction that truncating variants of X-linked genes 
impose more severe pathogenic effects on males than females. Data indeed indicate 
that truncations in STAG2 are indeed less tolerated in males. 
 
In addition to mutations, copy number variations (CNVs) have also been described for 
STAG2 through genome-wide array comparative genome hybridization (CGH) or X-
chromosome exome sequencing (Bonnet et al. 2009; Di Benedetto et al. 2014; Kumar 
et al. 2015; Leroy et al. 2016; Philippe et al. 2013; Yingjun et al. 2015). The CNVs consist 
of (micro)duplications or triplications of Xq25 in which the shortest region of overlap 
contains STAG2. These cases show that increased dosage can also lead to a 
cohesinopathy phenotype.  
 
Overall, patients with mutations in STAG1 or STAG2 share the core clinical findings of 
cohesinopathies, including intellectual disability, developmental delay and dysmorphism, 
but tend towards the mild end of the spectrum. Their phenotypes are highly 
heterogeneous and the clinical severity likely depends on numerous factors, such as the 
type and position of the mutation, and the X chromosome inactivation (XCi) process in 
females in the case of STAG2 (Mullegama et al. 2019). 
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There is still a limited number of cases but STAG1 and STAG2 should be considered as 
new cohesinopathy genes. Identification of novel patients can further expand the 
phenotype and provide a platform for functional studies. 
 
 
5.3 Cohesin mutations in cancer 
 
Cohesin was first associated with cancer when mutations in genes encoding cohesin 
subunits and its loader were identified by targeted sequencing in colorectal cancer 
(Barber et al. 2008). A few years later, loss of function mutations in STAG2 were found 
in glioblastoma, Ewing sarcoma and melanoma samples (Solomon et al. 2011). This 
study showed that correction of mutant alleles in glioblastoma cell lines restored 
chromosome cohesion defects without altering the transcriptional profile, hinting to mis-
segregation as the main pathogenic consequence of cohesin dysfunction. More recently, 
large projects of cancer genome sequencing have identified recurrent somatic mutations 
in genes encoding cohesin subunits or its regulators across many cancer types, pointing 
to the cohesin network as one of the most frequently mutated in cancer (Kandoth et al. 
2014; Lawrence et al. 2014; Leiserson et al. 2015; Martincorena et al. 2017) (Fig. I12). 
Contrary to initial theories, more recent functional studies indicate that most tumors or 
cancer cell lines analyzed do not show a clear correlation between cohesin mutational 
status and aneuploidy (Balbas-Martinez et al. 2013; Kim et al. 2016; Welch et al. 2012). 
This suggests that cohesin dysfunction contributes to cancer pathogenesis through 
alternative mechanisms, possibly transcriptional deregulation. 
 
Overall, STAG2 harbored a significantly higher proportion of inactivating mutations than 
other genes in the cohesin network and was appointed as one of twelve genes 
significantly mutated in at least four tumor types, along with well-established cancer 
genes such as TP53, PTEN and KRAS (Lawrence et al. 2014). STAG2 mutations were 
particularly prevalent in bladder cancer, myeloid malignancies and Ewing sarcoma but 
occur in a wide spectrum of cancer types. 
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Figure I12. Frequency of mutation in genes encoding cohesin core subunits in cancer. 
The cohesin pathway, including core cohesin subunits as well as cohesin regulatory factors, 
is frequently mutated in multiple cancer types. Data obtained from cBioportal. 
 
 
Although the prognostic impact of cohesin mutations has long been controversial (Kihara 
et al. 2014; Thol et al. 2014; Thota et al. 2014), retrospective analysis found that cohesin 
mutations trend towards a worse prognosis (Haferlach et al. 2014; Thol et al. 2014; Thota 
et al. 2014). Clonal analysis showed that cohesin mutations are present in the major 
tumor population, indicating they are early events in tumorigenesis (Kon et al. 2013; 
Thota et al. 2014), and discrimination by variant allele frequency suggests that mutations 
are in the dominant clone but not in the founder clone (Jan et al. 2012; Thol et al. 2014).  
These findings indicate that cohesin mutations could represent a transformative event 
towards more aggressive disease or that they provide a specific genetic context for the 
acquisition of additional mutations that promote tumorigenesis. 
 
Many efforts have been made towards understanding the role of cohesin mutations in 
myeloid cancers. Sequencing studies have revealed a prevalence close to 10% of 
cohesin mutations in acute myeloid leukemia (AML) and other myeloid malignancies. 
Functional studies have shed light on the contribution of cohesin mutations to 
tumorigenesis. When SMC1A and RAD21 AML-derived mutations were introduced in 
hematopoietic stem and progenitor cells (HSPCs), there were no changes in proliferation 
but differentiation was impaired. Increased accessibility was observed in regions 
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enriched for DNA-binding motifs of ERG, GATA2 and RUNX1, transcription factors 
involved in maintenance of the HSPC stemness programs (Mazumdar et al. 2015). 
 
Two additional studies have explored the consequences of cohesin knock-down in 
hematopoiesis, in vivo using shRNAs against SMC1A, Rad21 and SA2 and a conditional 
knock out of SMC3. SMC3 haploinsufficiency resulted in increased self-renewal of 
HSPCs and reduced expression of lineage commitment genes (Mullenders et al. 2015; 
Viny et al. 2015). 
 
Despite differences in model systems, taken together these studies strongly suggest that 
decreased cohesin levels may promote tumorigenesis through delaying or skewing 
HSPC differentiation and enforcing stem-cell programs instead. They appear to do so 
through modulation of chromatin accessibility to transcription factors involved in stem-
cell maintenance. Importantly, reduced cohesin dosage by itself did not result in AML, 
but it enhanced tumorigenesis when combined with other alterations. This is consistent 
with the idea that cohesin mutations cooperate with additional mutations to promote 
malignancy. 
 
These findings, together with the lack of correlation with aneuploidy, provide mounting 
evidence to support a mechanism whereby cohesin mutations alter 3D genomic 
organization and gene regulation. In the case of SA2-deficient tumors, SA1 likely allows 
survival by ensuring sufficient cohesion, but in turn cannot compensate SA2-specific 
roles, leading to a loss in the fidelity of chromatin loops with important functional 
consequences. 
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Objectives 
 
The main goal of this Thesis was to further clarify the functional specificity of somatic 
cohesin variants: cohesin-SA1 and cohesin-SA2. To this end, we generated a novel 
knock out mouse model for SA2 to serve as a tool for in vitro and in vivo studies. More 
specifically, our aims were: 
 
1. Assess effects of SA2 depletion on cohesion-related functions in mouse 
embryonic fibroblasts (MEFs). 
 
2. Address the genome-wide distribution of cohesin-SA1 and cohesin-SA2 and their 
contribution to gene regulation in MEFs. 
 
3. Evaluate the role of cohesin-SA2 in murine embryonic development. 
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Objetivos 
 
El objetivo principal de esta Tesis era esclarecer en mayor detalle la especificidad 
funcional de las variantes somáticas de cohesina: cohesina-SA1 y cohesina-SA2. Para 
ello generamos un nuevo modelo mutante de ratón para SA2 como base para estudios 
in vitro e in vivo. Nuestros objetivos específcos eran: 
 
1. Estudiar los efectos de la depleción de SA2 en funciones relacionadas con la 
cohesión en fibroblastos embrionarios de ratón (MEFs). 
 
2. Caracterizar la distribución de la cohesina-SA1 y la cohesina-SA2 a lo largo del 
genoma y su contribución a la regulación génica. 
 
3. Evaluar el papel de la cohesina-SA2 durante el desarrollo embrionario de ratón. 
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Materials and methods 
 
Stag2 cKO mouse model generation. The targeting vector PG00032_A_D11-3 was 
obtained from EUCOMM and electroporated into G4 mouse embryonic stem cells. 
Clones were selected in G418 and screened by Southern blotting for homologous 
recombination. Positive clones were infected with adeno-FLP to remove the selection 
cassette and create the conditional allele and microinjected into C57BL/6BrdCrHsd-Tyr 
morulae (CNIO Transgenic Mice core unit). Germline transmitting chimeras were 
screened by PCR (using primers Stag2_F and Stag2_R1; see Table M1) and selected 
to generate the mice colonies. More details in Results section 1 and Fig. R1. 
 
Mouse housing. Mice were housed in a pathogen-free animal facility following the 
animal care standards of the institution. All animal procedures were approved by local 
and regional ethics committees (Institutional Animal Care and Use Committee and Ethics 
Committee for Research and Animal Welfare, Instituto de Salud Carlos III) and 
performed according to the European Union guidelines.  
 
Mice strains. Mice carrying the Stag2 cKO allele were crossed with mice carrying Cre 
transgenes under the control of different promoters: Tg.hUBC-CreERT2 (Ruzankina et 
al. 2007) for MEF isolation and in vitro studies, and Tg.CAG-Cre (Belteki et al. 2005) 
2005) and Tg.Sox2-Cre (Hayashi et al. 2002) for embryo analyses. All mice strains were 
maintained in a predominantly C57BL/6 background. 
 
Timed matings. Male and female mice of reproductive age were placed together 
overnight. The next morning, females were checked for vaginal plugs to determine if 
mating had occurred. If the female was pregnant, time of plug detection was considered 
day E0.5 of embryonic development. Embryos were collected between E8.5 and E12-5, 
after palpation of females to confirm pregnant status. 
 
MEF isolation, culture and immortalization. Primary MEFs were isolated from E12.5 
embryos. Pregnant females were sacrificed in a CO2 chamber, uterine horns were 
dissected and transferred to a sterile PBS solution. Embryos were extracted from the 
uterus in a laminar flow hood. Fetal liver was excised and the head was taken for 
subsequent genotyping (using Stag2_F+R and CreERT2_F+R; see table M1). The rest 
of the embryonic tissue was minced with a scalpel and treated with 0.25% trypsin-EDTA 
(Sigma-Aldrich) for 10 min at 37ºC. Cells were further disgregated by pipetting and 
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resuspended in 9 mL medium. Primary MEFs were routinely grown in DMEM (Lonza) 
supplemented with 20% FBS (Sigma-Aldrich) and 1% penicillin-streptomycin, in an 
incubator at 37ºC under 90% humidity and 5% CO2. All experiments were performed in 
primary low passage MEFs except for FRAP, for which MEFs were immortalized using 
the SV40 large T antigen. Immortalized MEFs were grown in DMEM with 10% FBS and 
antibiotics. 
 
Stag2 ablation in culture. Stag2 cKO MEFs were treated with 1 µM 4-hydroxy 
tamoxifen (4-OHT) for 4 days in asynchronous cultures (20% FBS) and for 3 days in 
serum-starved conditions (0.1% FBS). The efficiency of depletion was assessed by 
immunoblotting (antibodies in Table M2). The same cells cultured without 4-OHT served 
as control. 
 
Immunoblotting. Whole cell extracts for immunoblot were prepared by lysing in 
Laemmli buffer at 10,000 cells/µl, sonicating and boiling for 5 min at 95ºC. SDS-
polyacrylamide gels and immunoblotting were performed following standard protocols. 
Custom-made primary antibodies were used at 2 µg/mL for 1 hour/RT and commercial 
antibodies following the manufacturer instructions (Table M2). Horseradish peroxidase 
(HRP)-conjugated secondary antibodies (Amersham Biosciences) were used at 1:5000 
dilution in 5% Milk for 1 hour/RT. ECL developing reagent (Amersham Biosciences) was 
used. 
 
Proliferation assays. MEFs pretreated for 4 days with 4-OHT were seeded at 11,000 
cells/cm2 in multiwell plates (3 triplicate wells per timepoint). Over the following days, 
cells were collected and counted in a Neubauer hemocytometer. 
 
Cell cycle analysis by FACS. MEFs grown at different conditions with or without 4-OHT 
were collected after a 30 min pulse with 30 µM BrdU (Sigma) and fixed overnight in 70% 
ethanol. DNA was denatured with 2N HCl for 20 min at RT. Cells were blocked with 1% 
BSA-0.05% Tween20 in PBS. Cells were incubated with a FITC-conjugated anti-BrdU 
antibody (Table M2) for 1h at 37ºC and DNA was stained overnight with 50 µg/ml 
propidium iodide (Sigma) with 10µg/mL RNase A (Qiagen). Flow cytometry was 
performed in a FACS Canto II cytometer (BD) and profiles were analyzed using FlowJo 
10.0.8 software. 
 
Cohesion and segregation analyses. To enrich MEFs in mitotic cells, they were serum-
starved for 3 days in media with 0.1% FBS in the presence or absence of 4-OHT and 
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released into media with 20% FBS for 36h. For chromosome spreads, 0.1 µg/ml 
colcemid was added to the medium 3-4 h before harvesting. Cells were swollen in 0.03M 
sodium citrate, fixed in methanol:acetic acid 3:1 and dropped onto slides. For anaphase 
analysis, cells were seeded onto coverslips at the time of release from G0 arrest. In both 
cases, cells were stained with 1 µg/ml DAPI, mounted with Vectashield and imaged using 
a Leica DM6000 microscope with LAS AF software. 
 
Chromatin Immunoprecipitation (ChIP). ChIP was performed in asynchronously 
growing MEFs as described (Remeseiro et al. 2012b). For each condition, two clones 
from different embryos were processed independently. Cells were cross-linked with 1% 
formaldehyde for 15 min at RT and quenched with 0.125M glycine. After two washes in 
PBS with 1 µM PMSF and protease inhibitors, cells were scraped, pelleted and lysed in 
lysis buffer (1% SDS, 10mM EDTA and 50mM Tris-HCl) at 20,000 cells/µL. Chromatin 
was sonicated in a Covaris system (shearing time 30 min, 20% duty cycle, intensity 6, 
200 cycles per burst, 30 sec per cycle). 25 µg of antibody was used to immunoprecipitate 
from 50 µg of sheared chromatin. Around 5 µg of immunoprecipitated chromatin per 
sample was used for library preparation. Adaptor-ligated libraries were generated by 
limited-cycle PCR with Illumina PE primers and were sequenced on an Illumina Genome 
Analyzer IIx platform. 
 
ChIP-sequencing analysis. Alignment of sequences to the reference mouse genome 
(mm9, February 2009) was performed using ‘Bowtie2′ (version 2.3.3.1) under default 
settings (Langmead & Salzberg 2012). Duplicates were removed using Picardtools 
(version 2.13.2) and peak calling was carried out using MACS2 (version 2.1.1.20160309) 
after setting the q-value (FDR) to 0.05 and using the ‘–extsize’ argument with the values 
obtained in the ‘macs2 predictd’ step (Zhang et al. 2008b). Mean read-density profiles 
and read-density heatmaps for different chromatin-binding proteins were generated with 
deepTools 2.5.4 (Ramírez et al. 2016). In addition to data generated in this study and in 
our group, we used publicly available datasets from Tedeschi et al. 2013 (GSE41603), 
Busslinger et al. 2017 (GSE76303) and ENCODE data for chromatin states 
(GSM1000139, GSM769028, GSM656318). Chromatin states were defined by exclusive 
presence of the following histone marks: H3K27ac and H3K4me1 for strong enhancers, 
H3K4me1 for weak enhancers, H3K27ac and H3K4me3 for strong promoters, H3K4me3 
for weak promoters, CTCF for insulators. “Rest” chromatin state contained none of the 
above. Motif enrichment analysis was performed with HOMER, using default parameters 
that screen the 200bp region surrounding the ChIP-seq peak summits. 
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Generation of cell lines with GFP-tagged cohesin subunits. One parental clone of 
immortalized MEFs was used to generate Rad21-, SA1- and SA2-GFP cell lines by 
CRISPR-Cas9 as described (Ladurner et al. 2016). Donor plasmids containing the C-
terminus of the targeted genes with in-frame GFP were created by Gibson Assembly. 
sgRNA sequences were designed using crispr.mit.edu (Table M3) and cloned in pX335 
plasmids, that also encode Cas9n-D10A. Plasmids were introduced into MEFs by 
electroporation with a Neon Transfection System (Thermofisher) applying 2 pulses of 20 
ms at 1400V. Positive cells were selected through an Influx Cell Sorter (BD) based on 
the GFP signal over control cells and the resulting polyclonal population was 
characterized by immunoblot and immunoprecipitation. More information in Results 
section 3.4 and 3.5. 
 
Antibody generation. New custom-made antibodies against the N-terminal end of SA1 
and SA2 were generated as part of this study, by using recombinant proteins with His-
MBP tag expressed in E. coli. Rat monoclonal antibodies were raised against residues 
1-223 of SA1 (CNIO Monoclonal Antibodies Unit). Rabbit polyclonal sera were obtained 
from rabbits injected with a fragment containing aminoacids 1-220 of SA2 and affinity 
purified. 
 
Biochemical fractionation and salt extraction. We followed the protocol from Méndez 
& Stillman 2000. Cells were resuspended at 2·107 cells/mL in buffer A (10 mM HEPES 
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 1 mM 
NaVO4, 0.5 mM NaF, 5 mM β-glycerophosphate, 0.1 mM PMSF), and incubated on ice 
for 5 min in the presence of 0.1% Triton X-100. Low-speed centrifugation (4 min/600 
g/4°C) allowed the separation of the cytosolic fraction (supernatant) and nuclei (pellet). 
Nuclei were washed and subjected to hypotonic lysis in buffer B (3 mM EDTA, 0.2 mM 
EGTA, 1 mM DTT, 1 mM NaVO4, 0.5 mM NaF, 5 mM β-glycerophosphate, 0.1 mM 
PMSF) 30 min on ice. Nucleoplasmic and chromatin fractions were separated after 
centrifugation (4 min/600 g/4°C). Chromatin was resuspended in Laemmli Sample Buffer 
and sonicated twice for 15 seconds at 20% amplitude. For salt extraction experiments, 
chromatin fractions were either left untreated or treated with 0.5M NaCl in modified buffer 
A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol and 
supplemented as above) for 30 min on ice. Solubilized proteins were separated from 
insoluble chromatin by low-speed centrifugation (4 min/600 g/4°C) and prepared for 
immunoblotting. 
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Immunoprecipitation, Asynchronously growing cells were lysed on ice for 30 min in 
lysis buffer [0.5% NP-40 in TBS supplemented with 0.5mM DTT, 0.1mM PMSF and 1X 
complete protease inhibitor cocktail (Roche)] and sonicated. Then NaCl was added to 
0.3M and the extract rotated for 30 min at 4ºC. Salt concentration was the lowered to 
0.1M NaCl by dilution and glycerol added to 10% final concentration. Extracts were 
incubated with the specific antibodies for 2h at 4ºC and rotated with 1/10 volume of 
protein A agarose beads for 1h at 4ºC. The beads were washed 6 times with 20 volume 
of lysis buffer and eluted in SDS-DTT gel loading buffer for 5min at 95ºC. 
 
Immunofluorescence in cultured cells. MEFs grown on coverslips were fixed with 4% 
PFA for 20 min and permeabilized in 0.25% Triton X-100 in PBS for 5 min on ice. Cells 
were blocked with 3% BSA, 0.05% Tween 20 in PBS for 30 min. Primary and secondary 
antibodies were diluted in blocking solution and incubated for 1h each. DNA was 
counterstained with 1 mg/ml DAPI. A Leica DM6000 microscope was used to obtain 
grayscale images, which were later analyzed using FIJI software. 
 
iFRAP. Cells were seeded in 8-well chambered coverslips (Ibidi) at 40,000 cells/cm2 48h 
prior to performing the experiment. The next day media was changed to 0.1% FBS for 
24h. iFRAP was performed in a Leica TCS-SP5 (AOBS) confocal microscope from 
Germany Leica Microsystems using a 40x/1.2 NA HCX PL APO objective with immersion 
oil. Cells were kept in a climate chamber at 37ºC with 5% CO2 during the experiment. 
Image acquisition used the HCSA software in LAS AF 2.7. Cells were photobleached 
with an argon laser and the recovery was monitored by live-cell imaging, Pictures were 
taken immediately before and after photobleaching as well as every 30 seconds during 
recovery. Videos were analyzed using FIJI software and statistical analysis and non-
linear regression with GraphPad Prism. 
 
RNA extraction from MEFs for RNA-sequencing. We collected 3 paired clones of 
asynchronous growing MEFs per condition. RNA was extracted with the RNeasy kit 
(Qiagen). PolyA+RNA was purified with the Dynabeads mRNA purification kit 
(Invitrogen), randomly fragmented and converted to double-stranded cDNA and further 
processed as in Illumina’s TruSeq RNA Sample Preparation Guide. Adapter-ligated 
libraries were made by limited-cycle PCR with Illumina PE primers and sequenced on 
HiSeq2000 or HiSeq2500 platform. 
 
RNA-sequencing analysis. Fastq files with single-end sequenced reads were quality-
checked with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ by S. 
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Andrews) and aligned to the mouse genome (mm9) with Nextpresso (Graña et al. 2018) 
executing TopHat-2.0.0 using Bowtie 0.12.7 and Samtools 0.1.16 allowing two 
mismatches and five multi-hits. Transcript assembly, estimation of their abundances and 
differential expression were calculated with Cufflinks 1.3.0 using the mouse genome 
annotation dataset NCBIM37/mm9 from Ensembl. To account for multiple-hypothesis 
testing, the estimated significance level (P value) was adjusted using Benjamini–
Hochberg FDR correction. We consider changes with FDR<0.05 and FPKM>2 as 
significant. GSEAPreranked was used to perform a gene set enrichment analysis (using 
also Nextpresso). 
 
Embryo extraction and processing for histology and immunofluorescence. Whole 
mount embryos were dissected in PBS at RT and imaged using a LEICA MZ10F 
microscope and LAS 3.8 software. DNA from the embryos or their yolk sac was extracted 
to genotype (using Stag2_F+R1, Stag2_F+R2, Sry_F+R, see Table M1). Embryos were 
fixed in a 10% formalin solution at pH 7 (Sigma HT501128-4L) overnight at 4ºC, 
dehydrated in an ethanol series and stored in ethanol 70% at 4ºC until further processing. 
Embryos were embedded in paraffin and sectioned at 5µm, longitudinally for embryos at 
E8.5 stage and transversely for embryos at E9.5 and E10.5. H-E was performed 
according to standard procedures and imaged with a Nikon Eclipse 90i microscope and 
NIS Elements D3.2 imaging software. Histology was evaluated in 2-4 embryos per 
genotype based on consecutive sections [WT1 (n=3), KO mild (n=4), WT2 (n=3) and KO 
severe (n=2) at E9.5; WT (n=3) and KO (n=3) at E10.5. For neural tube and aortas, 
section at the height of the heart chambers were taken. 
 
Immunofluorescence staining of embryo sections. Co-immunostaining for H3P-
TUNEL-ISL1 (Table M1) was performed on 4 embryos per genotype at E9.5 (WT1, KO 
and WT2). For TUNEL, the Terminal Transferase recombinant kit (Roche 03 333 574 
001) and biotin-16-dUTP (Roche 11 093 070 910) were used. Sections were imaged 
with a Nikon A1R confocal microscope and NIS Elements 4.30 software. For analysis, 
2-3 non-consecutive sections were analyzed per embryo. H3P signal was quantified with 
a custom-made Image J macro, taking into account both late G2 and M-phase signals. 
Single ISL1 staining was performed on 4 embryos per genotype at E8.5 (WT and KO) 
and imaged as above. 4 sections were analyzed per embryo. Statistical significance was 
determined by Kruskal-Wallis test and Dunn’s Multiple Comparison post-test using 
GraphPad Prism 5.03. 
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Embryo dissection, RNA extraction and RNA-sequencing. Whole-mount embryos 
were dissected in cold PBS. We used E9.5 WT and KO embryos with 21-23 pairs of 
somites. Heart tissue (whole heart along with surrounding SHF regions) and neural tube 
tissue (a section of heart-proximal neural tube) were dissected under a LEICA MZ10F 
microscope. Samples were immediately snap-frozen and stored at -80ºC. Per genotype 
and region, 3 replicates from 3 embryos each were pooled using TRI reagent (Sigma 
T9424) and homogenized by multiple passages through a syringe and needles (25-30G). 
Chloroform and phase lock tubes (QuantaBio 2302830) were used for phase separation 
and a subsequent precipitation with ethanol was performed at -20 ºC. RNA samples were 
analyzed using a Bioanalyzer 2100 (Agilent) and the RNA 6000 Pico kit. Libraries were 
prepared using the QuantSeq 3’ mRNA-seq Library Prep Kit FWD (Lexogen) and 
sequenced (10 million single reads per sample) on an Illumina HiSeq 2500 platform. 
 
RNA-sequencing analysis. For alignment and gene counting, we applied the Lexogen 
QuantSeq 2.2.3 pipeline provided by BlueBee, designed for use with the libraries 
described above. We removed one of the WT heart replicates due to initial inferior RNA 
integrity and a failure to cluster with the rest of the WT heart samples. The differential 
expression analyses have been performed with DeSeq2, excluding genes with no reads 
in any of the samples. Results were filtered by p-value<0.05 and FDR<0.05. In the 
heatmaps, color intensities correspond to the relative expression levels for each gene 
among conditions, normalized using the mean and standard deviation. Gene Ontology 
(GO) Enrichment Analysis was performed using Panther (Mi et al. 2013), using only gene 
sets with less than 1,000 genes to exclude the most general GO terms. GSEAPreranked 
was used to perform a gene set enrichment analysis (Subramanian et al. 2007) using 
the normalized counts provided by DeSeq2 using the default parameters.  
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Table M1. Primers for genotyping mice and embryos. 
Primer Sequence 5'-3' 
Stag2_F TGGTGCTTGGGATCAGATTT 
Stag2_R1 TCCCTCATCAAAGTCGAAAA 
Stag2_R2 AACAGCCTGAGCAAAGAATCC 
Sry_F TGGGACTGGTGACAATTGTC 
Sry_R GAGTACAGGTGTGCAGCTCT 
CreERT2_F TGAAGCTCCGGTTTTGAACT 
CreERT2_R GGTTCTTGCGAACCTCATCAC 
 
 
Table M2. Antibodies used in this study. 
Antibody Reference Use 
SA1 rat monoclonal (Nt) This study, Kojic et al. 2018 
Undiluted supernatant for 
immunoblotting (IB) 
SA1 rabbit polyclonal Remeseiro et al. 2012b 2 µg/ml  for immunofluorescence (IF) 
SA2 mouse monoclonal sc-81852 (SCBT) 1:100 for IF 
SA2 rabbit polyclonal (Nt) This study 2 µg/ml  for IB 
Rad21 rabbit polyclonal Carretero et al. 2013 2 µg/ml  for IB 
MEK2 mouse monoclonal M24520 (BD) 1:2000 for IB 
BrdU-FITC 556028 (BD) 1:50 for flow cytometry 
SMC1 Remeseiro et al. 2012b for IP and ChIP 
CTCF 07-729 (Millipore) for ChIP 
H3 1791 (Abcam) 1:10000 for IB 
ISL1 mouse monoclonal 39.4D5 (DSHB Hybridoma Bank) 1:100 for IF 
H3P rabbit polyclonal 06-570 (Millipore) 1:200 for IF 
 
 
Table M3. sgRNA sequences used for CRISPR. 
Primer Sequence 5'-3' 
SA1-sg1 CACCGTCTTCAGACTTCAGAACAT 
SA1-sg2 CACCGCTCTATTATTTAGAGCTAG 
SA2-sg1 CACCGCCCAAGAACCTAATGAGAG 
SA2-sg2 CACCGCAGTACACATTTAAATCTG 
Rad21-sg1 CACCGGTGACATCATTGCAACCCC 
Rad21-sg2 CACCGTCTAGCTCCTCAGATAATA 
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Results 
 
1. Generation of a conditional knock out mouse model for SA2 
 
In order to explore the role of cohesin-SA2 on multiple levels, we decided to generate a 
conditional knock out (cKO) mouse model for Stag2. For this purpose, we purchased a 
targeting vector from the European Conditional Mouse Mutagenesis program 
(EUCOMM) that allows the generation of a knock out first allele with conditional potential. 
The vector provides homology arms of 4.1 and 5.2 kb that promote recombination into 
the Stag2 locus, located on chromosome X, where it targets exon 7 out of 38. In the 
sequence corresponding to intron 6 it contains an FRT-flanked cassette with a splicing 
acceptor site (SA), a neomycin resistance selection gene (neo) and a polyadenylation 
sequence (pA). In addition, the vector contains exon 7 flanked by loxP sites (Fig. R1A). 
When the FRT-flanked cassette is present, transcription is terminated at the pA, 
generating a null allele (Stag2frt). This cassette can be excised by action of the 
recombinase Flippase (Flp), which recognizes and recombines the FRT (Flp Recognition 
Target) sequences. This leaves only the loxP sites flanking the targeted exon, thus 
creating a conditional allele (Stag2lox). These sites can be recognized and recombined 
by another recombinase, Cre. When this excision occurs, a null allele is produced 
(Stag2Δ; Fig. R1B). 
 
The targeting vector was introduced in mouse embryonic stem cells (mESCs) by 
electroporation and clones were screened by Southern blotting using two probes (Fig. 
R1C). Correctly targeted clones were infected with adeno-Flp to eliminate the FRT 
cassette and convert the allele to its conditional configuration. Next, selected clones of 
ES cells were microinjected into blastocysts and implanted into pseudopregnant 
mothers. Chimeras with germline transmission were selected to establish a mouse 
colony and genotypes were routinely confirmed by PCR analyses of genomic DNA (Fig. 
R1D). This mouse model served us to obtain Stag2 cKO mouse embryo fibroblasts 
(MEFs) to assess cohesin-SA2 function in cultured cells and to address its relevance for 
murine embryogenesis. 
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Figure R1. Generation of a novel knock-out mouse model for Stag2 by gene targeting. 
A. Map of the targeting vector obtained from EUCOMM to target the murine Stag2 gene. 
B. Scheme representing the targeting of the Stag2 allele and its conversion to different 
configurations in the presence of flippase (Flp) or Cre recombinases: + (wild type), 
frt (knock out first), lox (conditional) and Δ (induced knock out). Primers used for 
genotyping are indicated. 
C. Southern blot analysis (left) and strategy (right) for selection of correctly targeted 
mESC clones. 
D. Genotyping PCR analyses to distinguish between the Stag2 conditional (lox) and wild 
type (+) alleles in mice, using F and R1 primers. 
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2. Specific roles of cohesin-SA2 in cell proliferation 
 
2.1 Generation of conditional knock out MEFs for SA2 
 
To assess basic cohesin functions we chose an in vitro approach using cKO MEFs 
obtained from the Stag2 mouse model described above. Conditional Stag2lox/lox females 
were mated with males carrying hUBC-CreERT2 (Fig. R2A). This transgene ubiquitously 
expresses a fusion protein of Cre recombinase and a mutant form of the estrogen 
receptor that, in presence of tamoxifen, is activated by translocation to the nucleus 
(Ruzankina et al. 2007). We extracted embryos at embryonic stage E12.5 and obtained 
MEF cultures by mechanical and chemical disgregation (Fig. R2A). After genotyping 
Stag2 and CreERT2, only male cKO MEFs (Stag2lox/Y; hUBC-CreERT2+/T) were kept. In 
these MEFs, SA2 depletion can be induced by addition of 4-hydroxy-tamoxifen (4-OHT) 
to the culture medium for 3-4 days. 
 
Figure R2. SA2 cKO MEFs as model for in vitro studies of cohesin variants. 
A. Scheme for the establishment of cKO MEF cultures. Stag2 conditional females were 
mated with males carrying one copy of the hUBC-CreERT2 transgene and embryos 
at stage E12.5 were extracted to prepare MEFs. Male embryos carrying CreERT2 
were selected, in which SA2 depletion could be induced by addition of 4-OHT to the 
culture medium. 
B. Immunoblot analysis of whole cell extracts from cKO MEFs derived from two different 
embryos (e1 and e2) untreated or treated with 4-OHT to deplete SA2 (WT and KO) 
for 4 days in culture. Decreasing amounts of WT MEF extract (shown as % of 
maximal) were loaded to estimate the remaining amount of SA2. MEK2 was used as 
a loading control. 
 
SA2 depletion was efficient upon addition of 4-OHT for 4 days, and SA2 protein levels in 
treated MEFs (KO; lanes 6 and 8 in Fig. R2B) typically dropped below 5% of the amount 
present in untreated MEFs (WT; lanes 5 and 7 in Fig. R2B), as seen by immunoblotting 
in whole cell extracts. In most cases, we observed a compensatory upregulation of SA1 
to variable extents. The efficient and reproducible depletion of SA2 made these cells a 
useful tool for further in vitro studies. 
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2.2 Slower proliferation and minor defects in S phase progression in MEFs 
depleted of SA2 
 
Our first observation in this system was that SA2-null MEFs (KO hereafter) were viable, 
as cells kept growing in the almost complete absence of SA2. However, they proliferated 
at slower rates than their wild type (WT) counterparts (Fig. R3A). For this proliferation 
assay cells were seeded at low confluence and in these conditions, KO MEFs were 
particularly sensitive. 
 
In order to test whether the reduced proliferation arises from problems in cell cycle 
progression we performed flow cytometry analysis. We pulse-labeled cells for 30 min 
with bromodeoxyuridine (BrdU), a synthetic thymidine analog which can be used 
together with the DNA stain to better distinguish cells in S phase (Fig. R3B). We did not 
find any significant difference in the cell cycle profiles of asynchronously growing WT 
and KO cells (Fig. R3C), suggesting they were not arrested at any given phase of the 
cell cycle. In all clones tested, a small but consistent reduction of BrdU-incorporating 
cells was observed among KO MEFs, but did not reach statistical significance (p=0.11). 
These data rather indicate that SA2-null MEFs cycle slower but mechanisms contributing 
to this phenotype remained unclear. 
 
 
Figure R3. Slower proliferation of SA2KO MEFs and normal cell cycle distribution. 
A. Growth curves of WT and KO MEFs representing the average fold increase in cell 
number relative to the number of cells seeded on day 1. Data from MEFs from 2 
embryos (n=2), each analyzed in triplicates (mean ± SEM). Mann-Whitney test; ** 
P<0.01, ns P≥0.05.      
B. Representative FACS profiles of asynchronously growing WT and KO MEFs. 
Propidium iodide (PI) histogram (left) and BrdU incorporation profiles with gated G1, 
S and G2/M populations (right). 
C. Quantification (mean ± SEM) of cell cycle phases as gated on the BrdU incorporation 
profiles in panel B. n=4. Mann-Whitney test; ns P≥0.05. 
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A recent report has shown that human RPE cells lacking SA2 arrest in late S phase, 
supporting a role for cohesin-SA2 in replication fork progression (Mondal et al. 2019). 
The arrest becomes very pronounced over time, so we wondered whether treating MEFs 
with 4-OHT for longer times would result in a stronger phenotype. We compared the cell 
cycle profiles of MEFs treated for 4 and 8 days with 4-OHT (Fig. R4A). Cells were 
efficiently depleted of SA2 (Fig. R4B) but the fraction of BrdU-incorporating cells was 
reduced to a similar extent in SA2KO MEFs after 4 and 8 days of treatment (p=0.1; Fig. 
R4C and R4D). 
 
 
Figure R4. No obvious cell cycle changes upon longer treatment with 4-OHT. 
A. Experimental scheme. 
B. Immunoblot of whole cell extracts of WT and KO MEFs that have been treated for 4 
or 8 days with 4-OHT. MEK2 is used as loading control. 
C. Representative PI histograms by FACS. 
D. Representative BrdU incorporation profiles. 
E. Quantification (mean ± SEM) of cells in S phase, as gated in panel D. n=3. Mann-
Whitney test; ns P≥0.05. 
 
We also examined whether cells severely depleted of cohesin-SA2 had any problem in 
cell cycle re-entry and S phase initiation and progression after being released from a 
quiescent state. Serum starved Stag2 cKO MEFs were cultured in the presence or 
absence of 4-OHT for 3 days, released in serum-rich media and monitored by flow 
cytometry after a BrdU pulse (Fig. R5A). MEFs with or without SA2 initiated S phase 
roughly at the same time (Fig. R5B and R5C), but the fraction of replicating cells was 
slightly smaller in the KO cells, especially at times 12 and 36 after release (p=0.07 and 
p=0.1, respectively). 
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Thus, SA2KO MEFs presented some minor defects in S phase progression that could 
contribute to their slower proliferation. We cannot discard that these defects might 
become more evident if S phase is challenged. 
 
Figure R5. Cell cycle reentry after G0 arrest in SA2KO MEFs. 
A. Experimental scheme. 
B. Representative BrdU incorporation profiles from FACS analysis at 12-24-36-48h 
after release from G0. 
C. Quantification (mean ± SEM) of BrdU-positive population (S phase). n=3. Mann-
Whitney test; ns P≥0.05. 
 
 
2.3 Cohesion defects in MEFs depleted of SA2 
 
Cohesin was discovered for its role in cohesion between sister chromatids. This 
cohesion is established during S phase and lasts until mitosis, when two different waves 
of cohesin dissociation from chromatin promote proper chromosome segregation. As 
mentioned in the introduction, our lab and others have reported a more prominent role 
for cohesin-SA1 and cohesin-SA2 in telomere and centromere cohesion, respectively, in 
different cell types. Therefore, we explored the effect of SA2 depletion on cohesion in 
our particular cellular model, focusing on centromere cohesion. 
 
Stag2 cKO primary MEFs were serum-starved for 3 days in presence or absence of 4-
OHT and subsequently released back into serum-rich medium for 36 hours to give cells 
enough time to reach mitosis (Fig. R6A). We examined centromere cohesion in 
metaphase spreads and distinguished two major phenotypes: (1) “loosened” cohesion, 
evidenced by increased distance between sister centromeres compared to normal 
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chromosomes in which the two sister centromeres are fused and (2) “lost” cohesion, 
characterized by complete unpairing of sister centromeres (Fig. R6B). We detected very 
few cases of the more dramatic phenotype among WT and KO MEFs (1.3% and 3% 
respectively, dark green in Fig. R6C). We did, however, observe a larger fraction of 
chromosomes per metaphase with loosened centromeres in KO MEFs compared to WT 
(26 % and 11% respectively, light green in Fig. R6C). 
 
Figure R6. Centromere cohesion defects in MEFs depleted of SA2. 
A. Representative metaphase spreads from WT and KO MEFs and examples of normal, 
separated and loosened centromeres. 
B. Quantification of centromeric cohesion defects (mean ± SEM). Each dot represents 
a single metaphase. At least 100 metaphases from MEFs from 3 different embryos 
were inspected. Scale bar, 10 µm. Mann-Whitney test; *** P<0.001, * P<0.05.  
 
These observations confirm a role for cohesin-SA2 in centromeric cohesion, as was 
previously described in other cell types. However, as the defects are very mild, it is clear 
that cohesin-SA1 and/or mechanisms contributing to cohesion other than cohesin 
provide sufficient cohesion at the centromere region of these cells in the absence of 
cohesin-SA2. 
 
2.4 Chromosome segregation defects in MEFs depleted of SA2 
 
To explore whether the mild centromere cohesion defects observed in cells lacking 
cohesin-SA2 have an impact on chromosome segregation, we looked at cells 
undergoing anaphase. As before, Stag2 cKO MEFs were cultured in low serum in the 
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presence or absence of 4-OHT for 3 days and seeded onto coverslips at the time of 
release into serum-rich medium. After 36h, coverslips were collected, fixed and stained 
for DNA. Anaphase figures were inspected for lagging chromosomes and chromatin 
bridges (Fig. R7A). WT MEFs proved to be prone to segregation defects (17% of 
anaphases). Importantly, we found an almost 2-fold increase in defects in KO MEFs 
(29% of anaphases; Fig. R7B), even though data variability renders this difference 
statistically non-significant. 
 
Figure R7. Increase in defective anaphases in SA2-deficient MEFs. 
A. Images of anaphase cells, either normal or defective, found among WT and KO 
MEFs. 
B. Quantification of anaphase defects (mean ± SEM), including lagging chromosomes 
and chromatin bridges. At least 100 anaphases from MEFs from 3 different 
embryos were inspected. Scale bar, 5 µm. Mann-Whitney test; ns P≥0.05. 
 
Next, we analyzed chromosome number in metaphases. We prepared metaphase 
spreads from MEFs that had been cycling in the presence of 4-OHT for variable times: 
36h after release from G0 (as in Fig. R6A), or 4 and 6 days in asynchronous conditions. 
In the first timepoint the number of chromosomes did not significantly differ from 40, 
which was to be expected as this cell population is only undergoing the first mitosis after 
release from G0 (Fig. R8A). In the case of KO MEFs treated for 4 days, we did find a 
significant deviation from the normal number of chromosomes (Fig. R8B), that was 
further increased after 6 days of treatment (Fig. R8C). 
 
Overall, we concluded that SA2-null MEFs, despite displaying only mild cohesion 
defects, indeed present a lower fidelity of chromosome segregation. We do not rule out 
that these segregation defects have origins other than cohesion defects. In any case, 
the accumulation of aneuploidies may lead to inviable cells, which could also contribute 
to the observed reduction in proliferation. 
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Figure R8. Reduced fidelity of chromosome segregation in SA2 depleted MEFs. 
A-C. Quantification of chromosome number frequency in metaphase spreads of WT and KO 
MEFs (mean ± SEM). The different timepoints refer to the time KO cells have been cycling 
in the presence of 4-OHT. In A, 36h refer to 3 days of 4-OHT treatment upon serum 
starvation, followed by 36h of release from the arrest (as in Fig. R6A). In B and C,4 and 6 
days indicate number of days in the presence of 4-OHT of asynchronously growing cells, 
respectively. For each condition, at least 100 metaphases from MEFs from 3 different 
embryos were inspected. Mann-Whitney test; *** P<0.001, ** P<0.01, * P<0.05, ns P≥0.05.      
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3. Specific roles of cohesin-SA2 in genome organization and 
gene regulation 
 
In addition to its canonical function in sister chromatid cohesion, cohesin is essential for 
genome organization in interphase. It does so by stabilizing cis chromatin loops of 
different range, mostly together with CTCF but also independently of this architectural 
protein. This section explores the specific roles of cohesin-SA2 in genome organization 
and their impact on gene regulation. For that, we have examined genome wide 
distribution of cohesin and the transcriptomes of WT and SA2 KO MEFs, as well as of 
SA1 KO MEFs, previously generated in our group. We have also compared the 
chromatin association dynamics of the two cohesin variants by live cell imaging.  
 
3.1 Different genome-wide distribution of cohesin-SA1 and cohesin-SA2 
 
To explore genomic distribution of both cohesin variants, chromatin immunoprecipitation 
followed by deep sequencing (ChIP-seq) with custom-made, validated antibodies 
against cohesin subunits was used. In particular, ChIP-seq was carried our for SA2 in 
WT and SA1 KO MEFs and for SMC1 in WT and SA2 KO MEFs. Additional datasets 
were obtained from published and unpublished studies from our own group (Remeseiro 
et al. 2012, Ana Cuadrado and Miguel Ruiz Torres Doctoral Thesis UAM 2017) or other 
groups (Busslinger et al. 2017; Tedeschi et al. 2013)(Tedeschi 2013, Busslinger 2017). 
Reads were aligned to mm9 version of the mouse genome, peaks were called using 
MACS2 with FDR <0.05 and data were visualized by creating read density heatmaps. 
 
First of all, we analyzed positions of SMC1 (which identify all cohesin complexes) and 
CTCF in WT MEFs and encountered two distinct populations of cohesin. A majority of 
cohesin positions (71%) overlapped with CTCF positions (75,071 CTCF-cohesin sites), 
while the other 29% did not (30,608 non-CTCF-cohesin sites, Fig. R9A). To explore 
whether both cohesin isoforms contributed to both types of positions, we layered these 
data with those obtained for SA1 and SA2 in WT MEFS. The two cohesin variants were 
robustly present at “CTCF-cohesin” sites, while cohesin-SA2 was predominant at non-
CTCF-cohesin positions (Fig. R9A). Analyses of cohesin distribution in SA1KO and 
SA2KO MEFs revealed that non-CTCF-cohesin positions were retained in the absence 
of SA1 but lost in the absence of SA2, while CTCF-cohesin positions were firmly 
maintained in the absence of either variant (Fig. R9B). 
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Figure R9. Two classes of genome-wide cohesin binding sites in MEFs. 
A. Read density heatmaps showing ChIP-seq read distribution of CTCF, SMC1, SA1 
and SA2 at common and SA2-only cohesin positions in WT MEFs. Reads are plotted 
in a 5 kb window around cohesin peak summits. 
B. Read density heatmaps for SMC1 distribution at common and SA2-only positions 
(from A) in SA1KO and SA2KO MEFs. 
C. Mead read density plot for SMC1 at common and SA2-only cohesin positions in WT 
MEFs. 
 
We conclude that both cohesin-SA1 and cohesin-SA2 occupy sites bound by CTCF 
independently of one another while cohesin-SA2 is the preferred complex at positions 
not bound by CTCF. Moreover, cohesin-SA1 cannot occupy these non-CTCF sites even 
when cohesin-SA2 is absent. We therefore refer to the positions shared between the two 
variant complexes as “common” positions, and those specific for cohesin-SA2 as “SA2-
only”-positions. 
 
In a further effort to understand the nature and function of these two types of positions, 
we observed that common cohesin positions had higher and narrower peaks than SA2-
only cohesin positions, as shown in the mean read density plot for SMC1 (Fig. R9C). 
This result suggests that SA2-only positions are more variable from cell to cell in the 
population and/or more transient than common positions. This idea urged us to explore 
possible differences in the association of cohesin variants with chromatin. 
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3.2 Cohesin-SA2 is less tightly bound to chromatin 
 
As an initial proxy to explore the strength of the association to chromatin of the two 
variant cohesin complexes, we performed a biochemical assay in which we challenged 
chromatin-bound proteins with a high salt concentration. We first isolated the chromatin 
fraction using a biochemical fractionation protocol, then incubated this fraction with a 
buffer containing 0.5M NaCl for a short time and finally assessed by immunoblot the 
protein fraction still bound to chromatin after treatment. 
 
First, we performed this assay in WT MEFs and observed that a larger amount of SA1 
remained on chromatin after salt extraction compared to SA2 (lanes 1 and 2 in Fig. 
R10A). Next, we confirmed this result in SA1KO and SA2KO MEFs, where we focused 
on Rad21 levels for a direct comparison. In SA1KO MEFs, which contain only cohesin-
SA2, a larger amount of Rad21 is extracted from chromatin upon salt treatment (lanes 3 
and 4 in Fig. R10A). Only 19% of Rad21 present in untreated chromatin remained bound 
to chromatin (Fig. R10B). In SA2KO MEFs, where the only remaining cohesin is cohesin-
SA1, the release of Rad21 is less pronounced (lanes 5 and 6 in Fig. R10A) and 62% of 
the protein present in unchallenged chromatin is still bound after salt incubation (Fig. 
R10B). In WT MEFs, an intermediate amount of Rad21 (42%) resists the salt extraction 
(lanes 1 and 2 in Fig. R10A; Fig. R10B), consistent with the presence of both cohesin 
variants. 
 
Figure R10. Cohesin-SA2 is more easily extracted from chromatin upon salt treatment. 
A. Immunoblot analysis of chromatin fractions untreated or treated with 0.5M NaCl in 
MEFs of different genotype (WT, SA1KO and SA2KO). 
B. Quantification of Rad21 from A.  Numbers above the bars indicate % of remaining 
cohesin, normalized to H3 levels and relative to the untreated condition in each case.  
 
Both results in WT and KO MEFs show that cohesin-SA2 is more sensitive to salt 
extraction than cohesin-SA1 and thus provide initial evidence to propose that cohesin-
SA2 is less strongly bound to chromatin. 
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3.3 iFRAP: an assay to measure cohesin dynamics 
 
A more refined method to address the dynamics of cohesin association to chromatin is 
a technique known as inverse Fluorescence Recovery After Photobleaching (iFRAP). 
This is a modification of the classical FRAP technique, which is used to evaluate mobility 
of fluorescently tagged proteins by photobleaching a small area within the cell and 
monitoring the recovery of fluorescence in that area with time-lapse imaging (Fig. R11A). 
iFRAP is typically applied for chromatin-bound proteins that have longer recovery times 
compared to soluble proteins in diffusion. In iFRAP, the bleached area is larger and 
monitoring times are longer than for soluble proteins (minutes vs. seconds). The rate of 
recovery is estimated by taking into account the redistribution of fluorescence in both the 
bleached area and the unbleached area (Fig. R11B). Since cohesin is mostly a 
chromatin-bound complex, iFRAP was a suitable technique to assess the dynamics of 
cohesin variants. 
 
Figure R11. Schematic representation of FRAP and iFRAP experiments. 
See text for details. 
 
3.4 Generation of cell lines with GFP-tagged cohesin subunits for iFRAP 
 
For iFRAP we needed to generate MEFs expressing cohesin subunits fused to a 
fluorescent tag. To ensure physiological expression of the tagged proteins, we performed 
genome editing of endogenous genes with CRISPR-Cas9. Unlike the rest of experiments 
in this thesis, we used MEFS that were immortalized by transduction with the large T 
antigen of the SV40 virus (iMEFs). Using the same parental WT iMEFs, we generated 
cell lines with GFP tags at the C-terminus of SA1, SA2 and Rad21 cohesin subunits. 
 
Instead of the classical system (Fig. R12A), we chose a modified system that relies on a 
mutated version of Cas9 (Cas9n-D10A; Fig. R12B) that, once it reaches its target guided 
by a small guide RNA (sgRNA), introduces a nick in the DNA instead of a double strand 
break (DSB) (Trevino & Zhang 2014). For the system to work, two sgRNAs direct the 
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Cas9 to introduce two nicks in opposite strands, leaving a 5’ overhang that is then 
repaired by HR (Fig. R12C). The need for two sgRNAs with limited offset reduces the 
off-target effects of this system. Homology arms that, in our case, target the C-terminus 
of each gene of interest, including an in-frame insertion of GFP right before the STOP 
codon are provided to be used as template for HR-repair. Paired sgRNA plasmids, along 
with a plasmid expressing the Cas9 nickase and the donor plasmid were electroporated 
into iMEFs. Cells that had substituted the WT allele with the GFP-fused version were 
selected by cell sorting based on the GFP signal and polyclonal populations were grown 
and used for our studies. We proceeded to validate these cell lines by immunoblot, 
immunofluorescence, chromatin fractionation and immunoprecipitation before 
performing iFRAP (Fig. R12D). 
 
 
Figure R12. Generation of GFP-tagged cell lines by CRISPR targeting. 
A. Wild type version of Cas9, that generates a DSB. 
B. Mutated nickase version of Cas9, Cas9n-D10A, that generates a nick. 
C. Double nickase system driven by two sgRNAs against opposite strands, generating 
a break with 5’ overhang. 
D. Schematic representation of the generation of GFP-tagged cell lines by 
electroporation until the iFRAP, the final assay. 
 
 
3.5 Validation of GFP-tagged cell lines 
 
To validate the successful targeting of the three cohesin subunits, we first looked at their 
GFP and cohesin levels by immunofluorescence in fixed cells. We could confirm the 
presence of cells positive for GFP. The GFP signal coincides with cohesin (SMC1) 
staining, both in localization to the nucleus and in its pattern (Fig. R13A). However, GFP-
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negative cells were also seen. As opposed to systems relying on overexpression, here 
GFP expression was limited to the endogenous expression of the targeted genes. This, 
combined with limited efficiency of co-transfection, rendered negative cells in the sorted 
population. However, this was not a major issue for iFRAP because this is a single-cell 
study. Since no difference in cohesin (SMC1) levels were detected between GFP-
negative and GFP-positive cells (Fig. R13A), we concluded that GFP tagging did not 
significantly interfere with expression of the subunits. 
 
Figure R13. Successful generation of cells with GFP-tagged cohesin subunits. 
A. Images from fluorescent microscope. GFP-tagged cells were stained with SMC1 
antibody and DAPI to counterstain DNA, whereas GFP signal was visualized directly.  
B. Immunoblot of whole-cell extracts from Rad21-, SA1- and SA2-GFP tagged 
polyclonal populations. MEK2 is used as a loading control. 
 
We next performed immunoblotting of total cell extracts of the three different cell lines. 
For Rad21-GFP, we observe the endogenous Rad21 band, along with a band that 
migrates at a higher molecular weight, corresponding to Rad21-GFP. The presence of 
both bands in the population can be explained because targeting most likely occurs in 
heterozygosity, with only one allele being tagged with GFP and coexisting with the WT 
protein. The endogenous band is more prominent, likely due to the presence of GFP-
negative cells in the population (lane 1 in Fig. R13B). For SA1 and SA2 we used newly 
generated antibodies against the N-terminal parts of the protein (Nt), which allowed 
correct detection of the C-terminal GFP-tagged proteins. For SA1-GFP, we could again 
detect both the endogenous and tagged band. The tagged band is more prominent, 
suggesting that the targeting was quite efficient (lane 2 in Fig. R13B). For SA2-GFP, we 
also detected bands for both endogenous and GFP-tagged versions. The gene encoding 
SA2 is located on the X chromosome, and since the MEFs come from a male embryo 
(XY), the lower and upper bands corresponding to untagged and tagged SA2 come from 
unedited and edited cells, respectively (lane 3 in Fig. R13B). 
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Chromatin fractionation of MEFs expressing SA1-GFP or SA2-GFP followed by 
immunoblot showed that tagged SA1 and SA2 proteins were present in the chromatin 
fraction and not in the soluble fractions, just like the endogenous proteins (Fig. R14A). 
Moreover, the two tagged proteins were pulled down with an antibody against SMC1 
(lanes 3 and 6 in Fig. R14B), suggesting they can form part of a cohesin ring. For the 
Rad21-GFP cell line we had previously obtained similar results (Miguel Ruiz Torres, 
Doctoral Thesis, UAM 2017). 
 
Figure R14. Validation of SA1- and SA2-GFP populations by chromatin fractionation 
and immunoprecipitation. 
A. Immunoblot of cellular fractions from SA1- and SA2-GFP tagged cells. Whole cell 
extract (WCE), cytosol (Cyt), nucleoplasm (Nuc) and chromatin-bound (Chr) fractions 
were loaded. MEK2 and H3 were used as controls for correct fractionation. 
B. Immunoprecipitations of SMC1 in SA1- and SA2-GFP tagged cells. IP with IgG 
antibody was used as a negative control. 3% of input and 30% of IP were loaded. 
 
Taking together these experiments, we have correctly generated cells with GFP-tagged 
SA1, SA2 and Rad21 subunits that are able to target chromatin and do so in the context 
of a cohesin complex. 
 
 
3.6 Different dynamic behavior of SA1 and SA2 by iFRAP 
 
During S phase, a “cohesive” cohesin population is generated to hold the sister 
chromatids together that is not sensitive to WAPL-mediated release and remains stably 
bound to chromatin until mitosis. To avoid this population and restrict our analyses to the 
dynamic cohesin population, we performed iFRAP experiments in cells arrested in G0. 
For this, cells were seeded at high confluence in a microslide plate and kept in low serum 
medium (0.1% FBS) for 1 day before taking them to the confocal microscope. A high-
potency laser was used to photobleach half of the nucleus of selected cells and 
fluorescence recovery was monitored with interval captures over the following 20 
minutes.  
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For each timepoint, the difference in mean fluorescence intensity between the bleached 
and unbleached areas relative to the initial difference at the time of bleaching was 
calculated. Results were normalized both to total fluorescence intensity of the nucleus 
and to the background signal. Average data were fitted to a single exponential curve.  
 
 
Figure R15. iFRAP reveals distinct dynamics of cohesin-SA1 and cohesin-SA2. 
A. Plot of fluorescence recovery in SA1-GFP, SA2-GFP and Rad21-GFP cell lines, 
representing the difference in mean fluorescence intensity between the bleached and 
the unbleached areas relative to the time of bleaching. Mean ± SEM are shown (thin 
line) and a single exponential curve fit has been applied (thick line). n=20 for Rad21-
GFP, n=24 for SA1-GFP and n=16 cells for SA2-GFP, from 4 independent 
experiments. 
B. Representative image sequences of iFRAP in SA1- and SA2-GFP cells, showing pre-
bleaching, post-bleaching and recovery frames. 
 
We observed that the recovery of fluorescence in the bleached area was faster in SA2-
GFP cells than in SA1-GFP cells, while Rad21-GFP behavior was in between both (Fig. 
R15A). Consistently, the residence times calculated in Graphpad were 1.08 minutes for 
SA2 and 5.56 minutes for SA1. The difference was clear at early timepoints (up to 10 
minutes) and all cell lines reached a similar final recovery at 20 minutes. Representative 
images are shown (Fig. R15B). 
 
This result indeed suggests that cohesin-SA2 is more dynamic in its association to 
chromatin than cohesin-SA1, with an average residence time on chromatin that is 5-fold 
shorter. 
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3.7 Preferential interaction of cohesin-SA2 with cohesin release factor 
WAPL 
 
To find a molecular explanation as to why cohesin variants presented this different 
dynamic behavior, we looked into differential interactions with one of the key proteins 
that modulate cohesin binding to chromatin: WAPL. We found that the amount of WAPL 
present in immunoprecipitates of cohesin obtained with an antibody against SMC1 was 
lower in SA2-null MEFs than in WT MEF extracts (Fig. R16). This result suggests that 
there is a preferential interaction of cohesin-SA2 complexes with WAPL. 
 
 
Figure R16. Preferential interaction of cohesin-SA2 with WAPL. 
Left, immunoblot analysis of SMC1 immunoprecipitates in SA2 WT and KO MEFs. Asterisk 
indicates a non-specific band in the WAPL immunoblot. Right, quantification of WAPL levels 
in input and immunoprecipitated relative to Rad21. 
 
With this new information, we wondered how depletion of WAPL would specifically affect 
the genome-wide positioning of cohesin, especially at SA2-only sites. A previous study 
had shown that WAPLKO MEFs had increased amount of cohesin on chromatin, that 
this cohesin was stably bound and that its genome wide distribution was similar to that 
of WT MEFs (Tedeschi et al. 2013). However, our reanalysis of these ChIP-seq data 
revealed that cohesin (SMC3) is lost specifically in SA2-only positions relative to 
common positions in the absence of WAPL (Fig. R17A). As these SA2-only positions are 
not detected when cohesin is stabilized on chromatin, they most likely depend on the 
dynamic behavior of cohesin-SA2. 
 
Cohesin-SA1, on the other hand, is less dynamic and, in WT cells, accumulates only in 
CTCF-bound sites. Reanalysis of ChIP-seq data from CTCFKO MEFs (Busslinger et al. 
2017) showed that the presence of cohesin-SA1 at common positions was drastically 
reduced in the absence of CTCF and instead the complex occupies SA2-only positions 
(Fig. R17B). A recent preprint reports that CTCF depletion in HeLa cells decreases the 
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stability of cohesin-SA1 binding to chromatin. Although we have failed to see an effect 
of CTCF knock down on the salt extractability of SA1 (data not shown), an attractive 
hypothesis is that stabilization of cohesin-SA1 at CTCF sites may render this variant less 
dynamic and unable to occupy the more dynamic SA2-only sites. 
 
Figure R17. Cohesin redistribution upon depletion of WAPL and CTCF. 
A. Read density heatmaps showing ChIP-seq read distribution of SMC3 at common and 
SA2-only cohesin positions in WT and WAPLKO MEFs. Reads are plotted in a 5 kb 
window around cohesin peak summits. Data obtained from Tedeschi et al. 2013 and 
reanalyzed. 
B. Read density heatmaps of SA1 distribution at common and SA2-only cohesin 
positions in WT and CTCFKO MEFs. Data obtained from Busslinger et al. 2017 and 
reanalyzed. 
 
Taken together, we propose that SA2-only sites are dependent on the dynamic behavior 
of cohesin-SA2 and that cohesin-SA1 may occupy these sites when not being retained 
by CTCF. 
 
3.8 SA2-only positions are enriched in active chromatin states and 
transcription factor binding motifs 
 
For further insight into the relevance of cohesin distribution in common and SA2-only 
sites, we asked about additional genomic features of these positions using chromatin 
states defined in MEFs. Common cohesin positions are mostly enriched in insulators 
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defined by the presence of CTCF and no other histone modification (pie chart on the left 
in Fig. R18A). In contrast, SA2-only positions are found mostly at enhancers and 
promoters, especially active ones (pie chart on the right in Fig. R18A). The exclusive 
presence of cohesin-SA2 at a subset of cis-regulatory elements suggests that this 
complex may have a non-redundant role in the regulation of gene expression. 
 
Figure R18. Chromatin states and motif analysis in common and SA2-only cohesin 
positions. 
A. Pie charts showing distribution of common and SA2-only positions in chromatin 
states defined by epigenetic marks in MEFs (ENCODE), defined as follows: H3K27ac 
and H3K4me1 for strong enhancers, H3K4me1 for weak enhancers, H3K27ac and 
H3K4me3 for strong promoters, H3K4me3 for weak promoters, CTCF for insulators, 
or none of the above for “rest”. 
B. Top 5 motifs enriched in common and SA2-only cohesin positions by Homer Known 
Motif Enrichment Analysis. Enrichment of the motif in the target sequences over the 
presence of the same motif in an equal number of randomly chosen sequences 
(background) is shown. 
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Motif enrichment analysis using HOMER in common and SA2-only cohesin positions 
also revealed differences in the binding sequences. In common positions the top 
enriched motif was CTCF, present in 61% of positions, closely followed by 
CTCFL/BORIS, its germline paralog. Motifs for additional transcription factors were also 
identified (Fig. R18B). In the SA2-only cohesin positions there is a notable enrichment 
of binding motifs for transcription factors from the AP-1 family (Fra1, Fra2, Atf3, BATF, 
JunB) and also transcription factors belonging to the TEAD family. 
 
The exclusive enrichment of certain transcription factor binding motifs in SA2-only 
positions suggest an important contribution of cohesin-SA2 present at these positions to 
transcriptional control independently of cohesin-SA1. 
 
 
3.9 Cells depleted of SA1 and SA2 have a different effect on gene 
expression 
 
To evaluate the specific contributions of cohesin-SA1 and cohesin-SA2 to gene 
regulation, we performed RNA-sequencing in 3 pairs of WT and Stag1 KO MEFs as well 
as 3 clones of Stag2 cKO MEFs treated or not with 4-OHT for 4 days. A total of 917 
differentially expressed genes (DEGs, FDR<0.05; fpkm>2 in at least one condition) were 
identified in SA1KO MEFs (370 upregulated, 547 downregulated, average log2FC 1.2 
and -2.1, respectively, range +6.5 to -6.2). A reduced number of DEGs, 246, was found 
after elimination of SA2 (65 genes upregulated, 181 downregulated, average log2FC 0.85 
and -0.93, respectively, range +2.4 to -3.3). The more extensive transcriptional 
deregulation of SA1KO MEFs can be in part due to the fact that we are comparing MEFs 
derived from different embryos, whereas to test the effect of SA2 elimination, MEFs are 
derived from the same embryo untreated (WT) or 4-OHT-treated (KO). 
 
Gene Set Enrichment Analysis (GSEA) uncovered radically different profiles of gene 
deregulation in the absence of either cohesin variant (Fig. R19). In fact, many 
significantly deregulated pathways (FDR<0.05), were altered in opposite directions (Fig. 
R19 and R20A). For instance, several pathways related to cell cycle and DNA repair 
were downregulated in SA2KO and upregulated in SA1KO MEFs (Fig. R20B). Pathways 
displaying the opposite trend, i.e. upregulated in SA2 KO and downregulated in SA1 KO 
MEFs were membrane-related processes including “Lysosome” or receptor signaling 
(Fig. R20C). 
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Figure R19. GSEA analysis of transcriptomes from SA1KO and SA2KO MEFs. 
Top 15 upregulated and downregulated KEGG pathways are shown for each condition out 
of all significantly deregulated pathways at FDR<0.05. The total number of significant 
pathways is indicated between brackets. 
 
 
Enrichment profiles for some pathways are displayed as examples and show the striking 
opposite effect of the absence of one or the other variant cohesin complex (Fig. R20B 
and R20C). The opposite transcriptional signatures observed between SA1KO and 
SA2KO MEFs points at important implications for both cohesin variants in gene 
regulation, but suggest that the mechanisms or targets of this control are different for 
cohesin-SA1 and cohesin-SA2. 
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Figure R20. Cells depleted of SA1 and SA2 have an opposite transcriptional signature. 
A. Venn diagram showing the overlap between KEGG pathways significantly up- or 
downregulated at FDR<0.05 in SA1KO and SA2KO MEFs. Data from GSEA. 
B-C. Enrichment plots of representative GSEA pathways that are upregulated in SA1KO 
and downregulated in SA2KO MEFs (B) or viceversa (C). Normalized enrichment score 
(NES) and FWER q-value are shown in each plot. 
 
 
We hypothesize that this different control of gene expression by cohesin-SA1 and 
cohesin-SA2 could be again related to their distinct dynamics of binding to chromatin. To 
further test this idea, we compared the transcriptomic changes described above with 
those previously obtained in MEFs lacking cohesin releasing factors Pds5A and Pds5B 
(Figure 21A). FRAP analyses in these cells had revealed a clear stabilization of cohesin 
dynamics in the absence of both Pds5 proteins (Pds5KO, Miguel Ruiz Torres Doctoral 
Thesis UAM 2017 and Morales et al. 2019). We found a significant overlap between the 
pathways downregulated in Pds5-deficient MEFs and those downregulated in SA2KO 
MEFs and upregulated in SA1KO MEFs (49 and 52%, respectively). Similarly, pathways 
upregulated in Pds5KOMEFs overlapped with pathways upregulated SA2-null MEFs and 
downregulated in SA1KO MEFs (27% and 42%) (Fig. R2B). Thus, stabilization of 
cohesin binding to chromatin by reducing Pds5 protein levels or by removing the more 
dynamic cohesin, cohesin-SA2, results in comparable gene expression changes. 
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Figure R21. The transcriptome of Pds5KO MEFs resembles that of SA2KO MEFs. 
A. Top 15 upregulated and downregulated KEGG pathways in Pds5KO MEFs out of all 
significantly deregulated pathways at FDR<0.05. The total number of significant 
pathways is indicated between brackets. Data from Miguel Ruiz Torres, Doctoral 
Thesis, UAM 2017. 
B. Plot indicating the percentage of overlap between upregulated and downregulated 
pathways in all three conditions (SA1KO, SA2KO and Pds5KO MEFs). 
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4. The relevance of cohesin-SA2 for embryonic development 
 
In the previous sections we have shown that cohesin-SA2 has unique roles in cell 
proliferation, genome organization and gene regulation in vitro. The next section 
explores the importance of these roles in the context of a developing embryo. 
 
 
4.1 SA2-null embryos die by E10.5 
We first asked whether cohesin-SA2 is essential for embryonic development. To achieve 
ubiquitous deletion of Stag2 from the zypote stage we used a CAG-Cre transgene 
expressing a Cre recombinase through a strong synthetic promoter (Belteki et al. 2005). 
SA2 conditional KO females (Stag2lox/lox) were mated with males carrying a wild type 
Stag2 allele and one copy of CAG-Cre (Stag2+/Y; CAG-Cre+/T). Since Stag2 is a X-linked 
gene, male embryos in the offsping would be either wild type (WT, Stag2lox/Y) or knock-
out (KO, Stag2Δ/Y), while females would be WT (Stag2lox/+) or heterozygous (HT, 
Stag2Δ/+), depending on inheritance of the Cre allele (Fig. R22A). Each of these four 
options has a probability of 25% according to normal mendelian inheritance. The viability 
of SA2-null embryos was assessed by extracting embryos from pregnant females at 
different embryonic stages, that were genotyped for the Stag2 allele and the presence 
of the Y chromosome by PCR (Fig. R22B).  
 
By E12.5 no SA2KO embryos were alive and few reabsorbed embryos were found. 
Embryos of the other genotypes were present at expected proportions (Fig. R22C). 
Three days earlier, by E9.5, alive SA2KO embryos were obtained at the expected 
frequency. Complete depletion of SA2 in these embryos was confirmed by 
immunofluorescence with an antibody against SA2 in sections of E9.5 WT and KO male 
embryos (Fig. 22D). Next, we extracted litters at E10.5 and observed that the vast 
majority of SA2KO embryos were dead, as evidenced by the lack of heartbeat (Fig. 22C). 
We conclude that in the absence of cohesin-SA2, embryonic lethality occurs between 
E9.5 and E10.5.  
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Figure R22. SA2-null embryos are embryonic lethal. 
A. Mating strategy to obtain SA2KO embryos. 
B. Strategy (top) and representative results (bottom) of embryo genotyping by PCR. 
Genomic DNA was extracted from embryo tissue or yolk sac. Amplification of the Sry 
gene was used to detect the Y chromosome.  
C. Table (left) and bar graph (right) showing the proportions obtained for each of the 
genotypes in the offspring from the mating indicated in A at indicated stages. 14, 7 
and 13 litters were obtained at E9.5, E10.5 and E12.5, respectively.  
D. Immunofluorescence staining for SA2 of transverse sections of neural tube and heart 
of WT and SA2KO embryos at E9.5. Nuclei are counterstained with DAPI. Scale bar, 
200 µm. 
 
 79 
 
4.2 SA2 heterozygous embryos survive at submendelian proportions 
With the mating strategy described above to obtain SA2KO male embryos, heterozygous 
females are also found in the offspring (HT, Fig. R22A). At mid-gestation they are present 
at near-normal ratios (HT, Fig. R22C). However, among the mice that reach birth from 
these crosses and are genotyped at the time of weaning, only half of the expected 
proportion of heterozygous female mice are obtained (HT, Fig. R23A). This suggests 
that a fraction of these females die between stage E12.5 and weaning. Those that 
survive appear as healthy as their WT female littermates (Fig. R23B). We hypothesize 
that they might have benefited from X-chromosome inactivation skewed towards the SA2 
null allele. We continue exploring the phenotype of SA2 loss exclusively in male 
embryos. 
 
Figure R23. Half of SA2 heterozygous females survive until adulthood. 
A. Table (left) and bar graph (right) showing genotypes obtained after weaning for the 
offspring of the mating in Fig. 22A. Data from 11 litters. 
B. Kaplan-Meier survival plot for WT (Stag2lox/+) and HT (Stag2D/+) females (n=15 mice 
of each genotype). 
 
 
4.3 Lethality in SA2-null embryos is not caused by placental defects 
A recent study has revealed the previously under-appreciated contribution of placental 
defects to early embryonic lethality (E9.5-14.5) of numerous mouse models (Perez-
Garcia et al. 2018). In order to rule out that this was the case for SA2-null embryos, male 
mice carrying one copy of the Sox2-Cre transgene (Stag2+/Y; Sox2-Cre+/T) were mated 
with SA2 conditional females (Stag2lox/lox). The Sox2 promoter drives Cre expression only 
in the epiblast thus ensuring that gene deletion does not take place in non-epiblast 
derived extraembryonic tissues, which remain WT (Hayashi et al. 2002). We observed 
that all SA2 KO embryos died by E12.5 (Fig. R24A), just as with the CAG-Cre allele. 
However, reabsorbed embryos found at this stage were a bit larger and had more 
integrity than the ones found at E12.5 after ubiquitous Cre expression, suggesting that 
embryo reabsorption and thus lethality happen slightly later (Fig. R24B). We can 
conclude that placental defects are not the main cause of lethality in SA2-null embryos 
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although they could contribute to accelerate it. Studies presented below were performed 
with SA2KO embryos carrying CAG-Cre. 
 
Figure R24. Lethality of SA2-null embryos is not due to extraembryonic defects. 
A. Table (top) and bar graph (bottom) showing the outcome of 3 litters obtained by 
mating SA2 conditional females with males carrying a Sox2-Cre transgene 
Genotypes for Stag2 are: female WT (lox/+), female HT (D/+), male WT (lox/Y), male 
KO (D/Y). 
B. Representative comparison between WT and SA2KO male embryos at stage E12.5 
using deletion mediated by either Sox2-Cre (Fig. R24A) or CAG-Cre (Fig. R22C). In 
the cartoons, red color indicates regions were Cre is activated and SA2 is depleted, 
as opposed to purple regions that remain WT. 
 
 
4.4 SA2-null embryos display a developmental delay 
To further explore the phenotype caused by SA2 depletion we inspected whole mount 
embryos. We focused our analysis on the male embryos (WT and SA2KO). At stage 
E9.5, prior to lethality, SA2KO embryos were already smaller in size than their WT 
littermates (Fig. R25A). We observed variability in the penetrance of the phenotype, as 
most SA2KO embryos did not display overt morphological defects (mild) but others 
presented alterations that went beyond the reduction in size (severe). These features 
were further enhanced at E10.5 (Fig. R25A, right). 
 
To determine if the difference in size stemmed from a developmental delay, we counted 
pairs of somites in whole-mount embryos. Somites are segments of paraxial mesoderm 
that form bilaterally along the dorsal axis of developing vertebrate embryos (Fig. R25B). 
They give rise to vertebrae, ribs, skin and skeletal muscles, among other structures 
(Gilbert 2000). For mouse embryonic development, the number of somites expected at 
each stage is well established (Fig. R25C, right). Because individual embryos within the 
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same litter can develop at slightly different rates, the number of somites is a good 
indicator of actual developmental stage.  
 
A significantly reduced number of somites was observed in mutant embryos starting at 
E9.5, indicating a clear developmental delay, while at E8.5 the somite counts were still 
similar. By E10.5 this difference was more pronounced and corresponded almost to a 1-
day lag (Fig. R25C).  Notably, there was no difference between the somite counts of 
SA2KO embryos of mild and severe phenotypes. Thus, loss of SA2 causes a generalized 
developmental delay, noticeable by E9.5 with variable penetrance. 
 
 
Figure R25. SA2-null embryos display a developmental delay starting at E9.5.  
A. Representative images of WT (Stag2lox/Y) and SA2KO (Stag2D/Y) male embryos at 
E9.5 and E10.5. SA2KO embryos can be classified into a mild and a severe 
phenotype. Scale bar, 1mm.  
B. Schematic representation of somites in an E9.5 embryo (left) and a real image at 
high magnification where somites can be appreciated. 
C. Somite number of WT and SA2KO embryos at indicated stages in embryos from 6 
litters at E8.5 (n=13 WT and n=10 SA2KO embryos), 9 litters at E9.5 (n= 19 WT and 
n=25 SA2KO) and 4 litters at E10.5 (n=10 WT and n=10 SA2KO). Two-tailed 
Student’s t-test, *** P<0.001, ** P<0.01, ns P≥0.05. At the right of the graph are the 
number of somites that correspond to each stage of murine development. 
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4.5 Global developmental defects in SA2-null embryos 
We examined mutant embryos by histology to unveil defects underlying embryonic 
lethality. We proceeded with paired male WT and SA2KO littermates but included an 
additional control consisting of male WT embryos from a different litter with the same 
number of somites as the SA2KO embryos. We have termed the littermate or age-
matched control embryos as WT1 and the somite- or stage-matched control embryos as 
WT2. This double comparison allowed us to set apart phenotypes caused by aberrant 
development from those due to developmental delay. 
 
Figure R26. Global developmental defects in SA2-null embryos at E9.5. 
Hematoxylin-eosin (H-E) stained transverse sections of male embryos of the indicated 
genotypes extracted at E9.5. Structures indicated on images are: neural tube (NT), aortas 
(A), pharynx (P), hindbrain (HB), forebrain (FB), otic vesicle (Ot) and optic vesicle (Op). 
Neural tube and dorsal aortas are taken from sections adjacent to the heart. Scale bars (valid 
for entire row): 100 µm for dorsal aortas, branchial arches and brain; 25 µm for otic and optic 
vesicles. 
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At E9.5, mutant embryos with the severe phenotype showed an aberrant morphology of 
all analysed structures (Fig. R26 and Fig. R27B). In contrast, most tissues and organs 
from SA2KO embryos with a milder phenotype did not show obvious malformations but 
they were clearly more similar to stage-matched (WT2) than to age-matched (WT1) 
controls (Fig. R26). Thus, the difference between SA2-proficient and -deficient littermate 
embryos appeared to be the result of developmental delay in the latter. A remarkable 
exception to this general trend was a selective defect in the developing heart. 
 
4.6 Heart morphogenesis in the developing embryo requires cohesin-SA2 
 
 
Figure R27. SA2-deficient embryos display heart defects. 
A. Scheme showing the different heart regions in a murine heart at E9.5 and adult 
stages. Adapted from Epstein et al. 2015. 
B. H-E stained transverse sections of different heart regions are shown: heart chambers 
(HC), inflow tract (IFT) and outflow tract (OFT). Regions within HC are: right atrium 
(RA), left atrium (LA), atrioventricular canal (AVC), right ventricle (RV); left ventricle 
(LV). Black arrowheads on HC indicate the position of the prospective septum 
between right and left chambers. Asterisks highlight the small size of the RV relative 
to the rest of the heart. White arrowhead points at the OFT curve. Scale bars (valid 
for entire row), 100 µm 
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At E9.5 the murine heart already presents a multichambered conformation as a result of 
linear heart tube extension. Two prospective ventricles and two prospective atria can be 
distinguished, although there is still no septation between them. The outflow tract (OFT) 
is a continuance of the ventricle that allows blood to flow out of the heart and will 
corresponds to the aorta and pulmonary trunk in an adult heart (Fig. R27A) (Kelly et al. 
2014). 
 
In E9.5 SA2KO embryos of the mild phenotype, the prospective atria and right ventricle 
were reduced in size compared to both controls (HC, heart chambers, in Fig. R27B).In 
contrast, no clear differences were found in the left ventricle Morphological defects were 
also observed in the OFT: SA2KO embryos showed an aberrant rightwards turning of 
the OFT at the junction with the ventricular myocardium when compared to stage-
matched controls (OFT in Fig. 27B). However, the inflow tract (IFT) appeared normal 
(IFT, Fig. R27B). The defects described above were exacerbated in mutants with a 
severe phenotype, septum which displayed distended atria and ventricles with no visible 
indication of a future between right and left chambers and abnormal right ventricle 
development (last column in Fig. R27B). In this case, both the OFT and the IFT were 
distended. 
 
Figure R28. Severe cardiac anomalies in SA2 deficient embryos by E10.5. 
H-E stained transverse sections of SA2KO and WT littermate embryos at E10.5. The sections 
shown encompass the neural tube and the heart chambers. Heart regions are indicated on 
the WT image as in A. Scale bar, 250 µm. 
 
Despite the variable penetrance of the phenotype by E9.5, all mutants displayed severe 
cardiac anomalies by E10.5. The heart morphology resembled that identified in the 
severe phenotype at E9.5, with distended structures. Heart chambers lacked 
trabeculation and the atrioventricular canal was underdeveloped. Extensive necrosis and 
apoptosis were seen (Fig. R28). 
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In summary, SA2 mutant embryos display specific cardiac defects by E9.5 in addition to 
generalized developmental defects. We hypothesize that defective heart function may 
account for the embryonic lethality of SA2-null embryos. For further studies we 
proceeded only with SA2KO embryos of the mild phenotype to isolate the most primary 
defects. 
 
4.7 SA1 and SA2 are ubiquitously expressed in E9.5 embryos 
 
While SA1 and SA2 are expressed in all somatic cells, there are reports of different ratios 
of these somatic cohesin variants in different cell types (Kojic et al. 2018). We therefore 
asked whether the observed histological defects could arise from different expression 
patterns of SA1 and SA2 in embryonic tissues. For instance, cells expressing 
predominantly SA2 could be more sensitive to depletion of this cohesin variant.  
 
Figure R30. Similar expression patterns of SA1 and SA2 in early embryos.  
T-distributed stochastic neighbor embedding (tSNE) plots from single-cell RNA-sequencing 
(scRNA-seq) data published in the indicated studies (left) and expression levels for SA1 and 
SA2 (middle and right). Different colors indicate different cell types. 
A. Data from n=1,205 cells from in E6.5-E7.75 embryos identifies 10 cell clusters 
(Scialdone et al. 2016). Scale indicates log10 normalized counts for SA1 and SA2 
transcripts. Data available at http://gastrulation.stemcells.cam.ac.uk/ scialdone2016. 
B. Data from from n=19,396 cells from embryos at E8.25 stage identifies 33 cell clusters 
(Ibarra-Soria et al. 2018). Scale indicates log10 normalized counts +1 for SA1 and 
SA2 transcripts. Data available at http://marionilab.cruk.cam.ac.uk/ organogenesis. 
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We first looked into single cell RNA-sequencing (scRNA-seq) data from two published 
studies performed in mouse embryos at stage E6.5-7.75 (Scialdone et al. 2016) and 
E8.25 (Ibarra-Soria et al. 2018). The data are visualized using a dimensionality reduction 
technique called t-distributed neighbor embedding (tSNE; Van Der Maaten & Hinton 
2008). For these datasets, the first two dimensions are shown and cells with similar 
transcriptional profiles are clustered into groups indicated by different colors. The relative 
expression levels of SA1 and SA2 were similar in all groups at E6.5-E7.75 (Fig. R30A) 
and E8.25 (Fig. R30B). Still unknown is how this RNA data corresponds with actual 
protein levels within the cell. 
 
Since these data come from embryos at earlier stages, we also tested the relative levels 
of SA1 and SA2 in E9.5 embryos, in which cardiac defects were observed but prior to 
lethality. We checked protein levels by immunofluorescence in sections of WT E9.5 
embryos with specific antibodies against SA1 and SA2. 
 
Figure R31.  Distribution of cohesin variants in the E9.5 embryo. 
Immunofluorescence co-staining of SA1 (red) and SA2 (green) in transverse sections 
containing the heart and neural tube of wild type E9.5 embryos. Nuclei are counterstained 
with DAPI (blue). Scale bar, 200 µm. 
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We detected widespread expression of SA1 and SA2 in all tissues (neural tube and heart 
are shown in Fig. R31). In the heart, we confirmed that both variants could be detected 
in all regions (heart chambers, IFT and OFT). Since we were using two distinct 
antibodies, one for SA1 and another for SA2, it was not possible to make conclusions 
about the absolute levels of the two proteins, but we could compare their ratio among 
different areas of the embryo. No obvious difference in the relative abundance of the two 
cohesin variants caught our attention when examining the heart and its adjacent regions. 
It is therefore unlikely that the specific cardiac defects observed at E9.5 are due to 
different expression levels of the two variants in heart and must instead result from a 
specific requirement of cohesin-SA2 in heart morphogenesis.  
 
4.8 Decreased proliferation and increased apoptosis in Stag2 mutant 
embryos  
To explore the cellular mechanisms underlying the observed defects in heart 
morphogenesis, and given the defects in chromosome segregation and cell proliferation 
previously identified in SA2 KO MEFs, we went on to analyse proliferation and apoptosis 
in SA2 KO embryos by immunostaining. Transverse sections of E9.5 embryos of the mild 
phenotype as well as WT1 and WT2 embryos containing the different regions of the 
heart, or the neural tube for comparison, were selected and labeled with anti-
phosphohistone H3 (H3P), Islet1 (ISL1), TUNEL and DAPI. 
 
Histone H3 phosphorylated in Ser10 is abundant all over chromatin in mitosis and is also 
present in the heterochromatin of cells in late G2 phase, in which a dotted pattern is 
observed (Fig. 32A, left). Islet 1 is a transcription factor that identifies cardiac progenitors 
of the secondary heart field lineage and, together with morphological criteria, served to 
delimit the anterior and posterior secondary heart field regions (ASHF and PSHF, 
respectively) contributing to the heart. We developed a custom-made ImageJ macro that 
segmented the nuclei stained with DAPI and classified them into H3P-positive or H3P-
negative (Fig. R32A, right). Examples of the stained sections are shown (Fig. R32B).  
Figure R32. Analysis of cell proliferation in E9.5 embryos.             > 
A. Example of image processing and analysis using a custom-made ImageJ macro. The 
original (left) and processed (right) images are shown. An H3P signal above 
threshold is converted to a binary signal (red), and nuclei negative or positive for H3P 
are contoured in yellow or light blue, respectively. 
B. Representative images of H3P staining in the indicated regions of the heart and the 
neural tube for comparison. Both original and processed images are shown, with 
corresponding insets. ISL1 (white) is only shown for regions that were defined based 
on its expression (ASHF and PSHF, marked with *). Scale bars (valid for entire 
column except insets), 100 µm. Quantifications are shown in Fig. R33. 
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Figure R32. Analysis of cell proliferation in E9.5 embryos. Legend on previous page. 
 
 89 
 
For each region, 9-12 sections coming from 3-4 embryos of each genotype were 
analysed and the values for each section were plotted (Fig. R33). The fraction of H3P-
positive cells in the heart chambers (HC in Fig. R33) was significantly lower in the 
mutants as compared to their littermate controls (WT1), but similar to their stage-
matched controls (WT2). The same was true for the anterior secondary heart field 
(ASHF) and the outfow tract (OFT), as well as the neural tube (NT), while in posterior 
secondary heart field (PSHF) and the inflow tract (IFT; Fig. R33). 
 
 
Figure R33. Reduced cell proliferation in SA2-null embryos. 
Quantification of H3P-positive cells as readout for proliferation in WT1 (age-matched control), 
KO (mild phenotype) and WT2 (stage-matched control) E9.5 embryos in the indicated 
regions (as in Fig. 32).  From 9-12 non-consecutive sections from 3-4 embryos were 
analyzed per genotype and region. Individual dots represent values for one section. Bars 
represent mean ± SEM. Kruskal-Wallis test and Dunn’s multiple comparison post-test; *** 
P<0.001, **<0.01, * P<0.05, ns P≥0.05. 
 
 
These same sections were co-stained with Terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL). This assay allows labeling of cells that accumulate 
fragmented DNA, massively present in apoptotic cells (Fig. R34A).  Overall, the fraction 
of TUNEL-positive cells was very low in the embryos and there was high inter-individual 
variability. In SA2KO embryos, we found an overall increased percentage of apoptotic 
cells compared to both controls. This difference was most notable in the neural tube, 
heart chambers and ASHF (Fig. R34B). 
 
In sight of these results, we propose that the global developmental delay observed in 
SA2 null embryos at E9.5 could be due to a decrease in proliferative capacity of mutant 
cells, with some contribution from increased apoptosis. 
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Figure R34. Increased apoptosis in SA2 null embryos. 
A. Schematic representation of the TUNEL assay as a readout of apoptotic cells. 
B. Representative images of TUNEL staining in neural tube of E9.5 embryos of the 
indicated genotypes.Scale bar, 100 µm. 
C. Quantification of TUNEL-positive cells in sections as in Fig. 32-33. At least 10 
sections from 3-4 embryos were analysed per genotype and region. Individual dots 
represent values for one section. Mean ± SEM are shown. Kruskal-Wallis test and 
Dunn’s multiple comparison post-test; *** P<0.001, * P<0.05, ns P≥0.05. 
 
 
4.9 Impaired deployment of progenitors into the heart tube in Stag2 mutant 
embryos  
 
While decreased proliferation might account for the global growth delay observed in the 
mutant embryos, it failed to explain why morphological defects were more evident in 
certain heart structures: the OFT, the right ventricle and the atria. Interestingly, these 
affected areas all derive from second heart field (SHF) progenitors, unlike the left 
ventricle, which derives from first heart field (FHF) (Kelly et al. 2014).  The SHF is a 
population of cardiac progenitors of pharyngeal mesoderm origin that lies adjacent to the 
heart. By mid-gestation, addition of these progenitors to the linear heart tube drives its 
elongation and looping (Fig. R35A). The SHF progenitors populate the heart tube 
through the arterial and venous poles into the heart chambers: anterior SHF (ASHF) 
progenitors add onto the arterial pole through the OFT and posterior SHF (PSHF) 
progenitors migrate into the venous pole, through the IFT (Fig. R35B). As they migrate 
into the heart they differentiate into cardiomyocytes, which correlates with a 
progressively lower expression of the transcription factor Islet 1 (ISL1) (Francou et al. 
2013; Kelly et al. 2014). 
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Figure R35. Two waves of progenitors in heart morphogenesis. 
A. Schematic representation of heart looping. Between the stages E8 and E9.5, the 
linear heart tube progressively turns into a multichambered structure by asymmetric 
morphogenesis. 
B. At E9.5, anterior secondary heart field (ASHF) and posterior secondary heart field 
(PSHF) progenitors migrate into the outflow (OFT) and inflow tracts (IFT) to populate 
the heart and contribute to its morphogenesis. 
 
 
As part of the histological characterization, we measured the length of the OFT curves 
in equivalent sections of E9.5 embryos (Fig. R35A). In mutant embryos the length of the 
inner and outer curves was reduced compared to both controls (Fig. R35B). Together 
with the selectivity of heart defects, this led us to hypothesize a problem in the migration 
of ASHF progenitors into the OFT of SA2 mutant embryos. 
 
Figure R35. Reduced outflow tract length in SA2-null embryos. 
A. Representative images of the outflow tract (OFT) in E9.5 embryos of the indicated 
genotypes. Inner and outer curve measurements are shown on the image for WT1 
as an example. 
B. Quantification of inner and outer OFT length in WT1, SA2KO and WT2 embryos at 
E9.5. 9-12 sections from 3-4 embryos were analyzed per genotype. Mean ± SEM are 
shown. Kruskal-Wallis test and Dunn’s multiple comparison post-test; *** P<0.001, * 
P<0.05, ns P≥0.05. 
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To test this possibility, we looked into the cellularity of the different heart regions. We 
quantified the total number of cells in the previously labeled E9.5 sections. In the neural 
tube, heart chambers and OFT, the cellularity of SA2KO embryos was significantly lower 
than in WT1 and similar to WT2 embryos (Fig. R36A), consistent with their reduced size 
and decreased proliferation rates (Fig. R26A and R33). In contrast, cell numbers in the 
ASHF were similar in SA2KO and WT1 littermates (Fig. R36A), despite mutants showing 
a reduced proliferation rate (Fig. R33). When we looked into the fraction of cells positive 
for ISL1, a transcription factor expressed in SHF progenitors that is progressively 
switched off as they migrate into the heart (Cai et al, 2013), we found that this fraction 
was similarly high in ASHF for all embryos. However, it decreased in the OFT of KO 
embryos compared to both controls (Fig. R36B), consistent with a failure of SHF 
progenitors to migrate efficiently into the OFT in SA2 null embryos. 
 
Figure R36. Evidence for impaired migration of anterior secondary heart field 
progenitors in the developing heart of SA2-null embryos. 
A. Quantification of total number of cells in E9.5 WT1 (age-matched control), KO (mild 
phenotype) and WT2 (stage-matched control) embryos in the indicated regions: 
neural tube (NT), heart chambers (HC), posterior secondary heart field (PSHF), 
inflow tract (IFT), anterior secondary heart field (ASHF) and outflow tract (OFT). 
B. Quantification of ISL1-positive cells in the ASHF and OFT regions of E9.5 WT1, KO 
and WT2 embryos. Mean ± SEM are shown. Kruskal-Wallis test and Dunn’s multiple 
comparison post-test; ** P<0.01, * P<0.05, ns P≥0.05. 
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We performed a similar analysis in E8.5-E875 embryos (Fig. R37A), at the onset of SHF 
migration into the heart tube (Kelly et al. 2014) and focused on the OFT and ASHF. WT 
and SA2KO littermates with similar number of somites were longitudinally sectioned and 
labeled with an anti-ISL1 antibody (Fig. R37B). In terms of cellularity, there was a slight 
but non-significant reduction in the total number of cells in OFT and ASHF in KO embryos 
(Fig. R37C), despite no significant developmental delay at this stage (Fig. R26). The 
number of ISL1+ cells followed the same trend as at E9.5, with a decrease in the 
progenitors in OFT (Fig. R37D). Although the difference was not statistically significant, 
it is likely that the problem arises when the migration process starts. 
 
Figure R37. Migration of ASHF progenitors in SA2-null embryos at E8.5. 
A. Representative images of whole-mount WT and SA2KO littermate embryos in 
embryos at E8.5. 
B. Representative longitudinal sections containing the outflow tract (OFT) and 
anterior secondary heart field (ASHF) regions in WT and SA2KO embryos 
labeled with anti-ISL1 (white). Nuclei are counterstained with DAPI (blue). 
C. Quantification of the cellularity in OFT and ASHF of E8.5 embryos. 12 sections 
from 4 embryos per genotype were quantified. 
D. Quantification of ISL1-positive cells in OFT and ASHF of E8.5 embryos. 
 
Altogether, these findings suggest that cohesin-SA2 loss results in accumulation of 
progenitors in the ASHF that fail to migrate efficiently into the heart tube, leading to 
morphological defects in ASHF derivatives such as the right ventricle and the OFT. 
Defects in migration of progenitors have already been suggested as the cause of heart 
defects in murine embryos and zebrafish deficient for the cohesin loader NIPBL (Muto 
et al. 2011; Santos et al. 2016). 
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4.10 Altered transcription of cardiac development regulators in Stag2 
mutant embryos  
To address if the role of cohesin in gene regulation could contribute to the phenotypes 
described above, we compared the heart transcriptomes of E9.5 WT and SA2KO 
embryos by RNA-seq. To exclude variation related to developmental stage, we selected 
WT and SA2KO littermate embryos with similar number of somites. To identify tissue-
specific changes, we compared heart and neural tube tissue adjacent to the heart. We 
used nine embryos of each genotype (3 pools of material from 3 embryos) to extract 
RNA. 
First of all, we compared the transcriptomes of heart and neural tube in WT embryos.  
We identified 1,881 differentially expressed genes (DEGs; FDR<0.05) that allowed us to 
define a neural-enriched and a cardiac-enriched gene set for embryos at this stage (765 
and 1,116 genes respectively; Fig. R38A). Gene Ontology (GO) analysis confirmed the 
functional specificity of these gene sets, as they were strongly enriched in pathways of 
tissue-specific processes (Fig. R38B).  
When comparing the expression of these genes between WT and SA2KO embryos, 
there was a greater overall impact of SA2 loss on expression in the heart than in neural 
tube (heatmap in Fig. R38A). The transcriptional differences among the neural and 
cardiac gene sets in both tissues can also be represented in density plots reflecting the 
log2 fold change in SA2KO over WT. In these plots, it is clear that there is a larger 
deviation of both neural and cardiac gene sets in the heart of SA2KO embryos than in 
the neural tube. In addition, tissue-specific genes (e.g. cardiac genes in heart) were 
downregulated, while non-tissue-specific genes (e.g. neural genes in heart) were overall 
upregulated (Fig. R38C). 
Pairwise comparisons between WT and SA2KO samples for each tissue identified 846 
DEGs in heart but only 5 in neural tube (FDR<0.05; Fig. R39A), consistent with a larger 
deregulation in heart upon SA2 loss, as described above. Among the heart DEGs there 
were 222 and 112 genes from the cardiac and neural gene sets, respectively, and 
according to Fisher’s exact test they were statistically overrepresented. This indicates 
that tissue-specific genes were preferentially affected by SA2 loss (Fig. R39B). 
Moreover, most cardiac genes were downregulated in the heart of SA2KO embryos, 
whereas the neural genes were upregulated therein (Fig. R39C). 
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Figure R38. Tissue-specific transcriptional deregulation in SA2 null embryos. 
A. Heatmap showing relative expression of 765 neural- and 1,116 cardiac- enriched 
genes in all RNA-seq samples. Gene sets were defined by differential expression 
between heart and neural tube samples (FDR<0.05). 
B. Gene Ontology (GO) analysis of neural- and cardiac-enriched genes (shaded in 
green and orange, respectively). Top 10 significantly enriched pathways are shown 
ranked according to FDR (FDR<0.05). 
C. Density plots displaying the differential expression (log2 fold change; log2FC) of gene 
sets from A in the two tissues.  
 
These findings agree with the proposed role of cohesin-SA2 in tissue-specific 
transcription, promoting activation of genes specifying a tissue (i.e., cardiac genes in 
heart) and repression of alternative gene programs (e.g., neural genes in heart) (Kojic et 
al. 2018). This role is very clear in the heart, where loss of SA2 has a bigger impact, but 
can also be seen in neural tube to a lesser extent. 
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In addition, a closer look at the list of DEGs in heart revealed several cardiomyocyte 
markers and well-established regulators of SHF among the downregulated genes (Fig. 
R39A, right). For instance, Fgf8 and Hand2 contribute to the survival of ASHF 
progenitors while Wnt5a activity is critical for their deployment into the OFT. These roles 
are consistent with the defects described in the previous section. 
 
Figure R39. Differential expression in the heart of SA2 null embryos. 
A. Heatmap of 846 DEGs between WT and SA2KO heart samples (FDR<0.05) from 
E9.5 embryos. Among the downregulated genes, we highlight some with 
established roles in cardiomyocyte differentiation and SHF regulation. 
B. Expected versus observed number of cardiac and neural genes found among the 
heart DEGs. The total number of expressed genes is 21,653. Fisher’s exact test; 
****<0.0001 (p<2E-12). 
C. Box plot of expression changes in the cardiac and neural genes identified as 
DEGs in heart  
 
Taken together, our data suggest an important role of SA2 in the control of the early 
cardiac transcriptional programs that is not assumed by SA1 in the SA2KO embryos and 
which, together with decreased proliferation, contributes to the observed defects in heart 
morphogenesis. 
  
 97 
 
 
 
 
 
 
Discussion 
 
  
 99 
 
Discussion 
 
As a major chromatin organizer, cohesin has a plethora of functions in DNA metabolism, 
including DNA replication, transcription, chromosome segregation and repair. A major 
challenge in cohesin biology has always been to understand how one complex can 
perform such varied functions. Actually, different isoforms exist of some cohesin subunits 
and accessory proteins, giving rise to different combinations that can potentially divide 
the labor. Diversifying composition is a common way for cells to fine-tune functions of 
complexes, and a close example can be found within the SMC family: condensin. 
Vertebrate cells contain two versions of condensin, I and II, that participate in 
chromosome condensation in a stepwise manner (Hirano 2005). 
 
In this Thesis we have focused on cohesin-SA1 and cohesin-SA2. SA1 and SA2 share 
a high degree of sequence homology and their specificity has been largely neglected. 
Previous studies have addressed the differential role of these two cohesin variants in 
basic cohesin functions (Canudas & Smith 2009; Remeseiro et al. 2012a), but more 
recently studies by our group and others have uncovered unique roles beyond cohesion 
(Cuadrado et al. 2019; Kojic et al. 2018; Viny et al. 2019). We have addressed unique 
roles of cohesin-SA2 in vitro as well as during embryonic development to further 
understand functional specificities. 
 
1. SA1 allows survival of SA2-null cells in vitro with mild proliferation 
defects 
 
While entailing some phenotypes, our studies in MEFs show that depletion of SA2 does 
not compromise cell survival. Consistent with previous studies in other cellular systems 
(Benedetti et al. 2017; Liu et al. 2018; van der Lelij et al. 2017), this confirms that the 
presence of either cohesin variant is sufficient to sustain cell viability in vitro and that  
SA1 and SA2 may compensate each other for the essential functions of cohesin. In this 
regard, the phenotype of SA1 or SA2 depletion may be due to reduced cohesin rather 
than specific defects. Only a fraction of the total amount of cohesin present in the cell is 
sufficient to promote cohesion during mitosis, as suggested by studies in budding yeast 
and Drosophila cells showing that cohesin levels need to drop below 13% or 20%, 
respectively, for cohesion loss to manifest (Carvalhal et al. 2018; Heidinger-Pauli et al. 
2010). We often observe upregulation of SA1 protein levels in MEFs after SA2 depletion, 
suggesting that the cell tries to compensate total cohesin levels. Therefore, there might 
 100 
 
be some specificity in the mechanisms promoting cohesion, despite the overall functional 
redundancy. 
 
As far as the basic functions of cohesin are concerned, SA2-null cells show phenotypes 
that are not unlike those in SA1-null cells (Remeseiro et al. 2012a). These include a 
reduction in proliferation, to which multiple mechanisms could contribute. Transcriptional 
analysis show that “Cell cycle”, “DNA replication” and multiple DNA repair pathways were 
all downregulated in SA2-depleted MEFs. 
 
Our analyses suggest that SA2 deficient MEFs progress slower through the cell cycle 
and show a mild defect in S phase progression. These results are in stark contrast with 
a recently published study that claims a strong role of SA2 in stability and progression of 
the replication fork in non-transformed cells. SA2 ablation in RPE cells caused intra-S-
phase arrest, replication fork collapse and accumulation of double strand breaks (DSB), 
leading to a senescent phenotype (Mondal et al. 2019). This same study showed how 
SA2-mutant cancer cell lines were more sensitive to DNA damaging chemotherapeutic 
agents and inhibitors of DSB-repair, compared to SA2-proficient ones. This is consistent 
with earlier reports of increased sensitivity of cohesin to PARP inhibitors(Bailey et al. 
2014; Mclellan et al. 2012; O’Neil et al. 2013). However, no strong S-phase defect was 
observed in our cellular model upon depletion of SA2. Differences in total and relative 
amounts of cohesin variants found in different cell lines could explain this, highlighting 
the importance of the system used.  
 
In addition, we observed defects in centromeric cohesion, agreeing with the previously 
described role for cohesin-SA2 in HeLa and mouse C2C12 cells (Canudas & Smith 2009; 
Remeseiro et al. 2012a). The defects were mild in nature, with cells usually showing 
increased distance between sister centromeres as opposed to fully separated ones, that 
could translate into reduced resistance to spindle forces. The presence of SA1 and/or 
alternative mechanisms contributing to cohesion likely make up for the loss of SA2. A 
fraction of SA2-deficient cells exhibits segregation defects and aneuploidies, which could 
lead to inviable cells and contribute to reduced proliferation. 
 
Despite reasonable maintenance of cohesion and overall viability in unchallenged 
conditions, SA2 deficient MEFs may be more sensitive to DNA damage  since previous 
studies have shown a preferential role of cohesin-SA2 over cohesin-SA1 in DNA repair 
(Kong et al. 2013; Meisenberg et al. 2019). This possibility remains to be addressed. 
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2. The different genomic distribution of cohesin-SA1 and cohesin-SA2 
reveals two classes of cohesin positions 
 
While both SA1 and SA2 may compensate for the essential functions of cohesin, at least 
in vitro, this might not be the case for other non-essential functions. As a major 
determinant of cohesin function in genome organization, we studied the genome-wide 
distribution of cohesin-SA1 and cohesin-SA2 in MEFs. We identified two major types of 
cohesin positions with differences in their colocalization with CTCF and their enrichment 
in functional genomic elements: common cohesin positions and SA2-only positions 
(illustrated in Fig. D1). 
 
Figure D1. Common and SA2-only cohesin positions. 
Simplified illustration of the two types of cohesin positions identified in MEFs. Common 
cohesin positions are shared by cohesin-SA1 and cohesin-SA2 and colocalize with 
architectural protein CTCF, forming large structural loops corresponding to TADs or sub-
TADs. SA2-only positions exist independently of CTCF creating more local contacts that are 
highly enriched in regulatory elements. 
 
Both cohesin-SA1 and cohesin-SA2 are present at common positions, which overlap 
with CTCF and largely correspond to the “insulator” chromatin state. At least a subset of 
these positions likely demarcate TADs or subTADs. The presence of CTCF is the major 
determinant of cohesin localization at these sites, as removing CTCF drastically 
decreases cohesin occupancy at these sites. They likely pose an obstacle for cohesin 
progression by loop extrusion (Busslinger et al. 2017; Haarhuis et al. 2017). The common 
nature of these position suggests that cohesin-SA1 and cohesin-SA2 can be similarly 
stopped here, and do so independently of the other cohesin variant, as was confirmed 
in SA1- and SA2-deficient MEFs. 
 
In contrast, SA2-only positions lack SA1, are exclusively made up of cohesin-SA2 and 
do not overlap with CTCF. They are highly enriched in chromatin states corresponding 
 102 
 
to active enhancers and promoters. CTCF-independent cohesin positions had been 
previously described and associated to binding of tissue-specific transcription factors, 
yet they were not clearly attributed to a specific cohesin variant (Faure et al. 2012; Kagey 
et al. 2010; Schmidt et al. 2010). Work from our group has shown that cohesin-SA2 is 
the variant present at non-CTCF cohesin sites in multiple cell types (this Thesis, 
Cuadrado et al. 2019; Kojic et al. 2018). 
 
Consistent with their different distribution, depletion of either isoform has a different 
impact on gene expression that affects a wide array of cellular processes, as shown by 
our transcriptome analysis. In fact, depletion of SA1 and SA2 in MEFs has strikingly 
opposite effects in terms of deregulated gene sets. Interestingly, a similar trend was 
observed in mESCs (Cuadrado et al. 2019). These results point to distinct mechanisms 
of gene regulation by cohesin-SA1 and cohesin-SA2, which remain to be elucidated. It 
also remains unclear which transcriptional effects are a consequence of global alteration 
of TAD structure, which result from alteration of a local contact involving the gene anf its 
regulatory element requiring cohesin and which correspond to secondary effects. 
 
The two types of cohesin positions identified exist among multiple cell types, including 
human cell lines of different embryonic origin, mESCs and mouse hematopoietic stem 
cells (Cuadrado et al. 2019; Kojic et al. 2018; Viny et al. 2019). This highlights their 
importance and points to a universal mechanism of genome organization by cohesin 
variants. What remains enigmatic is how different cohesin complexes can occupy 
different positions. 
 
3. Distinct dynamic behavior of cohesin-SA1 and cohesin-SA2 and its 
functional relevance 
 
Common cohesin positions have a high cohesin occupancy and correspond to narrow 
peaks. SA2-only positions, in contrast, have lower cohesin occupancy and display 
broader profiles. Since ChIP-seq is a population study, it shows the cumulative binding 
across many cells at the time of crosslinking. Therefore, robust cohesin positions likely 
reflect the presence of cohesin at these sites in a large number of cells from the 
population. These cells could present either cohesin-SA1 or cohesin-SA2 at these sites, 
or both variants at the same time. Re-ChIP experiments have shown that at least in some 
common positions more than one cohesin complex can be present (Kojic et al. 2018). 
Weaker cohesin positions, on the other hand, could correspond to sites found in a 
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minority of cells at a given time. It is likely that these positions are more transient and 
therefore overall less represented in the population. 
 
The weaker nature of SA2-only positions suggested to us that cohesin-SA2 present at 
SA2-only positions was more dynamic. Biochemically, we showed that overall SA1 was 
less sensitive to salt extraction than SA2, which was more readily destabilized. This 
experiment allowed us to conclude that SA2 is less tightly associated to chromatin but 
did not speak directly to cohesin dynamics. iFRAP experiments allowed us to address 
this directly and demonstrated that cohesin-SA2 has a more dynamic behavior than 
cohesin-SA1. 
 
We suspected that the molecular reason behind this could be related to different 
susceptibilities to cohesin release factors such as WAPL. We observed a decreased 
interaction of cohesin with WAPL upon depletion of SA2, suggesting that this factor 
preferentially associates to cohesin-SA2. Immunoprecipitation experiments in human 
cell extracts have shown a similar preferential interaction of SA2 with WAPL (Kojic et al. 
2018). Moreover, upon WAPL depletion SA2-only positions are selectively reduced, 
suggesting that they rely on cohesin dynamics. 
 
Interestingly, a highly related study in our lab has shown an increased WAPL/SA2 ratio 
associated to SA2-only positions compared to common positions, by ChIP-qPCR in 
MCF10A cells (Kojic et al. 2018). These data indicated that the higher susceptibility to 
WAPL of cohesin-SA2 was not general to the entire pool of cohesin-SA2, but rather 
restricted to the population found at SA2-only sites. This raised the possibility that 
cohesin at common positions, comprising cohesin-SA1 and/or cohesin-SA2, could be 
protected from WAPL unloading. These positions are sites of CTCF binding. Intriguingly, 
the region of SA2 that interacts with CTCF has been narrowed down to residues 162-
290 by in vitro pull-down assays (Xiao et al. 2011), and residues very close to this region 
(positions 290, 326 and 330) are key for binding to WAPL (Hara et al. 2014). This raises 
the possibility of competitive binding of CTCF and WAPL to the SA subunit of cohesin. 
Although the region in question is highly conserved between SA1 and SA2, the 
preference to either factor could be slightly different for both variants, with SA1 preferring 
CTCF and SA2 preferring WAPL. 
 
With these data in mind, we envision a model in which cohesin extrudes chromatin until 
released by WAPL or until it reaches CTCF sites, where WAPL accessibility is impaired, 
possibly by WAPL-CTCF competition. We propose that cohesin-SA1 can reach CTCF 
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boundaries with a higher frequency than cohesin-SA2 and is therefore stabilized on 
chromatin for longer times. Cohesin-SA2, on the other hand, is more susceptible to 
WAPL release during loop formation, leading to a higher turnover on chromatin. 
However, once it reaches CTCF sites, interaction with CTCF equally stabilizes it by 
protection from WAPL (Fig. D2). It is also possible that physical stacking of several 
cohesin rings at a single common position also physically hinders WAPL accessibility. 
 
Figure D2. Cohesin-SA2 at SA2-only positions is more susceptible to WAPL-mediated 
release. 
Model proposing that cohesin-SA2 is more sensitive to WAPL-mediated release from 
chromatin, leading to a higher turnover. The presence of CTCF or potential cohesin stacking 
at common positions could protect them from WAPL activity, leading to more stable positions. 
 
We believe the distinct dynamic behavior and genomic localization to be directly relevant 
to the role of cohesin in transcription. Establishment of different types of contacts can 
dictate gene expression and explain why depletion of SA1 and SA2 have different effects 
on transcription.  
 
Considering the differences between cohesin at common and SA2-only sites in terms of 
association with WAPL and CTCF, we postulate that cohesin dynamics should change 
upon depletion of CTCF or cohesin removal factors WAPL (Fig. D3). In the absence of 
CTCF, cohesin would not be protected from WAPL-mediated release and cohesin-SA1 
would adopt a more dynamic behavior. This would agree with our observation that 
cohesin-SA1 can occupy SA2-only positions when CTCF is absent. Upon depletion of 
WAPL it has already been shown that cohesin’s residence time on chromatin is 
extremely increased (Tedeschi et al. 2013), and we think this would primarily affect SA2, 
just as it would in a PDS5 KO situation. A preprint showing how SA1 and SA2 dynamics 
change in these backgrounds has been recently posted (Wutz 2019), confirming some 
of these hypotheses. 
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Figure D3. Potential behavior of SA1 and SA2 in iFRAP experiments in different 
backgrounds. 
Blue and red continuous lines represent results obtained in our iFRAP analysis for SA1-GFP 
and SA2-GFP, respectively. CTCF KO (light blue dashed line) likely makes SA1 more similar 
to SA2 in terms of dynamics, as cohesin at common positions would no longer be protected 
from WAPL-mediated removal. In an opposite fashion, depletion of WAPL (orange dashed 
line) would make SA2 behave more like SA1. 
 
 
In addition to differential dynamics, we must not forget the importance of specific 
interacting partners. Non-CTCF-cohesin, now identified as cohesin-SA2, has previously 
been shown to correlate extensively with binding of tissue-specific transcription factors 
by ChIP-seq (Faure et al. 2012; Schmidt et al. 2010). In our group we have also shown 
direct interaction of SA2 with transcriptional regulators like YAP1 and ZMYM2 in both 
HeLa and MCF10A cells (Kojic et al. 2018).  Moreover, we have shown that SA2-only 
positions are enriched in binding motifs from specific transcription factors, such as the 
AP-1 and TEAD families, that are different to those found in common positions. 
Therefore, it is plausible that SA2 can uniquely interact with certain transcriptional 
regulators. The elucidation of the full structure of SA subunits, comprising the least 
conserved regions between SA1 and SA2, may give important clues in this regard. 
 
 
4. Both cohesin variants are essential for mouse embryonic development 
 
In contrast to the redundancy and functional compensation of SA proteins in vitro, mouse 
embryos require both proteins to fulfill their development. Previous work from our group 
showed that constitutive inactivation of Stag1 in the germline is embryonic lethal, with 
incomplete penetrance, starting at stage E11.5. SA1-null embryos displayed a severe 
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developmental delay but no obvious organ malformation (Remeseiro et al. 2012b). In 
this Thesis we have shown that inactivation of Stag2 in the germline leads to an earlier 
and more abrupt lethality, starting at E9.5. The phenotype is associated with a 
developmental delay and a broad, subtle tissue disorganization, with the exception of 
severely impaired heart development. In first instance, this tells us that successful 
development relies on the presence of both cohesin variants, and that neither can 
compensate for the other in its absence. Thus, during the formation of a multicellular 
organism, both SA1 and SA2 have unique and non-redundant roles. 
 
Both SA1- and SA2-null embryos share a common phenotype: developmental delay. In 
both cases this could be inferred from embryo size but it was also precisely quantified 
for SA2-null embryos through somite counts. As in cell cultures, reduced proliferation 
was observed in SA2-null embryos, a defect that likely contributes to the growth 
retardation. This could also happen in SA1-null embryos, although it was not assessed. 
In both cases, there is a variable penetrance of the phenotype. A plausible explanation 
is the variable compensation of expression of the remaining cohesin variant, and as a 
result, different global cohesin levels between embryos. We have indeed seen variable 
upregulation of SA1 protein levels in MEFs upon SA2 depletion, suggesting the same 
variable compensation could happen in vivo and lead to different outcomes. 
 
In SA2-null mice lethality occurs quite early and no embryos survive beyond E10.5. Other 
mouse models partially deficient for genes crucial in cell proliferation survive to later 
stages of development. For example, mice carrying hypomorph alleles of the MCM3 
subunit of the replicative helicase survive until E16.5-18.5, and their associated lethality 
seemingly results from impaired expansion of hematopoietic precursors (Alvarez et al. 
2015). Mutant mice in the centrosome component Cep57 that display more severe 
chromosome segregation anomalies than those reported for SA2-null MEFs also survive 
to birth (Aziz et al. 2018). Therefore, we believe it is unlikely that defects in proliferation 
alone account for the lethality of SA2 KO embryos. 
 
 
5. Heart defects in SA2-null embryos 
 
In addition to the systemic developmental delay, SA2-null embryos present a very 
overpowering defect in the developing heart. Defects were observed in other tissues, but 
these were coupled to the developmental delay, which was clarified by comparison with 
stage-matched controls. Proliferation defects were not specific to the heart and were 
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observed in all regions analyzed, suggesting that additional processes are altered during 
cardiac morphogenesis in the absence of SA2. Interestingly, histological defects did not 
affect the heart entirely but were restricted to the right ventricle, outflow tract and atria, 
regions that all derive from the second heart field (SHF). 
 
At early stages of embryonic development, a linear heart tube is formed from first heart 
field (FHF) progenitors. At approximately stage E8.5, contribution of the second heart 
field (SHF) pool of progenitors to anterior and posterior poles of the heart induces heart 
looping, breaking the symmetry of the heart and giving rise to a multi-chambered 
structure. This event is crucial for heart morphogenesis and relies on rapid proliferation 
of SHF progenitors that migrate into the heart tube as they differentiate (Francou et al. 
2013). 
 
Figure D4. Impaired deployment of SHF progenitor into the heart tube of SA2-null 
embryos. 
Impaired differentiation caused by absence of SA2, as well as decreased proliferation, likely 
cause the impaired migration of ASHF progenitors into the heart tube of SA2-mutant 
embryos, leading to morphological defects in regions directly derived from this population 
(marked with *). 
 
Our detailed analysis of SHF cells and cellularity suggest that migration of anterior SHF 
(ASHF) progenitors is impaired in SA2-null embryos (Fig. D4). This could explain 
morphological defects in the regions that derive from these progenitors, for example the 
shortened OFT or the hypoplastic right ventricle. This idea was reinforced by the finding 
of transcriptional downregulation of key regulators of SHF in the heart of SA2-deficient 
embryos. To further confirm this hypothesis, lineage tracing experiments in vivo would 
be very suitable, using a SHF-specific enhancer-driven reporter system to directly 
monitor the contribution of SHF cells to the heart tube. 
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As discussed above, increasing evidence supports the notion that the presence of 
cohesin-SA2 at regulatory elements independently of CTCF promotes cell type-specific 
transcription, a function that cohesin-SA1 cannot compensate (Cuadrado et al. 2019; 
Kojic et al. 2018; Viny et al. 2019). From these studies, we know that common cohesin 
positions are highly conserved, while SA2-only sites are highly cell-type specific (Kojic 
et al. 2018). In mESCs it was shown that cohesin-SA1 contributes mainly to global 
chromatin architecture while cohesin-SA2 had additional roles in mediating contacts 
important for repression of lineage commitment genes and maintenance of pluripotency 
(Cuadrado et al. 2019). Altogether, this suggests that cohesin-SA2 plays a crucial role 
in enforcing the correct transcriptional programs in accordance to developmental state 
and cell type. We hypothesized that cohesin-SA2 would be highly relevant during 
morphogenesis to rewire transcription and promote lineage commitment. Comparison of 
transcriptomes of heart and neural tube from WT E9.5 embryos allowed us to define 
tissue-specific expression profiles corresponding to this stage of development. 
Consistent with this idea, transcriptome analyses uncovered altered tissue-specific 
transcription patterns in SA2-null embryonic hearts, with lower expression of cardiac 
genes and de-repression of genes from the neural lineage. This trend was also observed 
in neural tube, although this tissue presented an overall smaller deregulation (Fig. D5). 
In our experiment, however, the dissection of whole hearts may dilute defects in specific 
populations like the SHF. Thus, this study would greatly benefit from single-cell RNAseq. 
 
 
Figure D5. Loss of cell identity in the absence of SA2. 
In normal conditions, SA2 is responsible for inducing tissue-specific transcription programs 
while repressing genes from other lineages. In the absence of SA2 there is a reduced lineage 
commitment and aberrant activation of genes from other lineages. 
 
Overall, we propose that defects in both proliferation and lineage specification driven by 
cohesin-SA2 contribute to the heart abnormalities observed in the SA2-deficient 
embryos. This was previously suggested in NIPBL-deficient mouse and zebrafish 
embryos (Kawauchi et al. 2016) or zebrafish with reduced cohesin levels that often failed 
to loop (Santos et al. 2016; Schuster et al. 2015). 
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However, it is still puzzling how aberrant development was so specific to the heart. We 
believe that heart defects are the main cause of death in SA2-null embryos. The heart is 
one of the first organs to start differentiating in the embryo, and the first one to become 
functional (Bruneau 2013). Heart failure would make embryos unable to sustain further 
development, thus masking potential defects in other organs that arise later in 
development. We predict that bypassing the heart defect, for example by restoring SA2 
expression specifically in the heart, would set back the lethality and allow the observation 
of developmental defects elsewhere in the embryo. This is backed up by the fact that in 
the neural tube we also observed deregulation of tissue-specific genes, although the 
magnitude of the changes was not significant.  
 
A possibility is that cohesin requirements change during development in different cell 
populations. During a particular developmental window in a particular cell type, the 
requirement for cohesin could peak, and cells in this window would be particularly 
sensitized to cohesin depletion (Fig. D6). This model was proposed by Schuster et al. 
2015.  
 
Figure D6. Model of fluctuation in cohesin requirements in different cell types 
during  
Model illustrating how cohesin requirements (purple curve) can change during 
development in different cell types. A small fraction of cohesin would be sufficient to 
perform cohesion, while the remaining fraction would be required for non-cohesive 
functions. It shows, hypothetically, how a modest decrease in cohesin levels (red dashed 
line) can sensitize a specific tissue to abnormal development at a given time if cohesin 
requirement are no longer met. Inspired from Schuster et al. 2015. 
 
In the graph, cohesin requirements of cell type 1 peaks sooner than for cell types 2 and 
3, and may therefore be the first to suffer from cohesin depletion. Cohesin-SA2 
requirements in cardiac progenitors could peak sooner than for other tissues that 
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undergo differentiation at later times. This model could explain why, at this given point 
of development, cardiac development is particularly dependent on cohesin-SA2. This is 
consistent with why there is a much larger transcriptional deregulation in the heart than 
in the neural tube. The lethality derived from cardiac defects may mask later dependency 
of other tissue types on cohesin-SA2.  
 
A study has shown that cohesin removal in differentiated macrophages causes limited 
effects on steady-state transcription but causes great alteration of inducible gene 
expression during inflammatory response (Cuartero et al. 2018). The authors conclude 
that cohesin’s role in transcriptional regulation is most relevant in when the cells needs 
to change its transcriptional program in response to stimuli. Not unlike this, we can 
envision how an abrupt rewiring of transcriptional programs needed for the transition of 
proliferation to lineage-commitment can create an increased requirement of cohesin, 
most likely of cohesin-SA2.  
 
 
6. Implications for human disease 
 
Our results in mouse embryos support a causative contribution of cohesin-SA2 function 
to the congenital heart anomalies detected in CdLS patients, most of them carrying 
mutations in NIPBL (Chatfield et al. 2012). As discussed in the introduction, 
cohesinopathy cases with STAG2 mutations have recently been reported too. Among 
those, male patients carry missense variants and show milder phenotypes that do not 
include heart defects, while ventricular septal defects and other heart anomalies have 
been described in female patients carrying loss of function or missense variants (Aoi et 
al. 2019; Kruszka et al. 2019; Lehalle et al. 2017; Mullegama et al. 2019; Soardi et al. 
2017; Yuan et al. 2019). STAG2 is an X-linked gene, which can explain why germline 
inactivating mutations are not tolerated in males while heterozygous females may 
survive through the selection of cells in which the wild type allele is not silenced by the 
X chromosome inactivation process. Accordingly, our model shows that male Stag2-null 
embryos are lethal, while a fraction of Stag2 heterozygous females can survive until 
adulthood. It would be of interest to study these females, regarding cohesin content, X 
chromosome inactivation and developmental aberrations, to gain more insights into 
human cases. 
 
We have showed evidence supporting the role of cohesin-SA2 in tissue-specific 
transcription in vivo during murine development. We believe that SA2 deficiency and the 
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consequent transcriptional deregulation could be a pathogenic mechanism underlying 
the developmental defects that arise in human developmental syndromes caused by 
STAG2 mutations. 
 
In the context of tumorigenesis, STAG2 harbors a significantly higher frequency of 
inactivating mutations that any other cohesin subunit or regulator. This can be in part 
due to the fact that it is encoded in the X chromosome and a single mutation is sufficient 
for inactivation. In addition, SA2 is non-essential for proliferation as it can be replaced by 
SA1. So far, few functional studies have been performed using cancer-associated SA2 
mutations to understand how its loss promotes tumorigenesis, but knowledge about 
unique functions of cohesin-SA2 is providing insight into this matter. 
 
Given the presence of cohesin-SA2 at regulatory elements and the inability of cohesin-
SA1 to localize at these positions, we propose that tumor cells benefit from deregulation 
of some key genes in the absence of SA2 that confer a favorable environment for tumor 
progression. Consistent with this idea, in the hematopoietic system, AML-derived 
cohesin mutations have been shown to promote malignant transformation by altering the 
balance between self-renewal and differentiation (Mazumdar et al. 2015). More 
specifically, a similar effect was shown upon downregulation of SA2 in hematopoietic 
precursors. In addition, aberrant expression of lineage commitment genes was directly 
linked to SA2-only cohesin positions (Viny et al. 2019). Therefore, it is possible that 
effects of total cohesin downregulation could majorly represent the effects of loss of 
cohesin-SA2. 
 
As mentioned before, both cohesin variants are essential for embryonic development but 
either one is sufficient for cohesion-related functions and cell viability. Not surprisingly, 
in vitro studies have recently nominated SA1 as a synthetic lethal target in SA2 mutant 
cell lines (Benedetti et al. 2017; Liu et al. 2018; van der Lelij et al. 2017). Selective 
inhibition of cohesin-SA1 has therapeutic potential to treat STAG2-mutated tumors, but 
given that SA1 and SA2 are so similar it will be challenging to find highly specific 
inhibitors. To this end, structural information about the floppy ends of the SA1 and SA2 
proteins might again prove useful. It will be also important to address the toxicity of 
STAG1 depletion in adult tissues.  
 
On a different note, it has been shown that the aberrant self-renewal and impaired 
differentiation induced by SA2 ablation in hematopoietic progenitors can be reversed by 
reactivation of key cohesin-SA2 target genes (Viny et al. 2019). This suggests that 
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restoring expression levels of critical targets regulated by SA2 could have a tumor 
suppressive effect and could therefore provide novel therapeutic opportunities. Overall, 
increasing knowledge about the specificities of cohesin-SA1 and cohesin-SA2 can help 
to further explore these roads. 
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Conclusions 
 
1. We successfully generated a conditional knock out mouse model for Stag2. 
 
2. SA2 is not essential for cell viability in vitro, but MEFs lacking SA2 display 
reduced proliferation, loosened centromeric cohesion and reduced fidelity in 
chromosome segregation. 
 
3. Genome-wide distribution of cohesin-SA1 and cohesin-SA2 is not equivalent. 
Both cohesin variants are found at CTCF sites, but only cohesin-SA2 can occupy 
non-CTCF cohesin positions enriched in active regulatory elements. Cohesin-
SA1 cannot bind to these positions even in the absence of SA2. 
 
4. Association of cohesin-SA2 with chromatin is more dynamic than association of 
cohesin-SA1. This is likely due to its preferential interaction with cohesin release 
factor WAPL. 
 
5. Depletion of SA1 or SA2 causes distinct changes on gene expression. 
 
6. Both cohesin variants are essential to fulfil mouse embryonic development. SA2-
null embryos are lethal by stage E10.5. 
 
7. SA2-deficient embryos present a widespread developmental delay that 
correlates with a decrease in cell proliferation and an increase in apoptosis. 
 
8. SA2-null embryos likely die of cardiac anomalies. They display specific 
malformations in regions derived from the second heart field and present an 
incorrect deployment of these progenitors into the heart tube at stage E9.5. 
 
9. SA2 ablation causes misexpression of second heart field regulators and 
alteration of tissue-specific transcription in mouse embryos prior to lethality. 
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Conclusiones 
 
1. Hemos generado un modelo de ratón mutante condicional para Stag2. 
 
2. SA2 no es esencial para la viabilidad celular in vitro, pero MEFs deficientes en 
SA2 presentan una proliferación reducida, una menor cohesion centromérica y 
una menor fidelidad en segregación cromosómica. 
 
3. La distribución de la cohesina-SA1 y la cohesina-SA2 a lo largo del genoma no 
es equivalente. Ambas se localizan en sitios de unión a CTCF, pero únicamente 
la cohesina-SA2 puede ocupar sitios sin CTCF enriquecidos en elementos 
reguladores de la transcripción. La cohesina-SA1 no puede ubicarse en estas 
posiciones incluso en ausencia de SA2. 
 
4. La asociación de la cohesina-SA2 a cromatina es más dinámica que la 
asociación de la cohesina-SA1, probablemente debido a su interacción 
preferencial con el factor de descarga WAPL. 
 
5. Depleción de SA1 o SA2 produce cambios diferentes en la expresión génica. 
 
6. Ambas variantes de cohesina son esenciales para completar el desarrollo 
murino. Los embriones deficientes en SA2 son letales a estadío E10.5. 
 
7. Los embriones deficientes en SA2 presentan un retraso generalizado en el 
desarrollo que correlaciona con una proliferación celular disminuida y un 
aumento en apoptosis. 
 
8. Es probable que la causa de la letalidad de los embriones deficientes en SA2 
sean sus anomalías cardiacas. Desarrollan malformaciones específicas en 
regiones derivadas del campo secundario y presentan una migración incorrecta 
de estos progenitores hacia el tubo cardiaco a estadío E9.5. 
 
9. La depleción de SA2 provoca una expresión aberrante de genes reguladores del 
campo secundario y una alteración en la transcripción específica de tejido en 
embriones antes de su letalidad.  
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